Skip to main content
SpringerLink
Log in

Nebenschilddrüsen

  • Chapter
  • First Online:
Praxis der Viszeralchirurgie

  • 5342 Accesses

Zusammenfassung

Die Nebenschilddrüsen stellen das Serumkalzium im Sinne einer "biologischen Konstante" ein. Mittels der raschen Anpassung der Parathormonsekretion justieren sie das Serumkalzium auf einen Sollwert. Jede Abweichung des Serumkalziums nach oben oder nach unten zeigt eine Fehlfunktion dieses Regelkreises an und bedarf einer Abklärung. Die Beurteilung dieses Regelkreises ist nur durch eine gleichzeitige Bestimmung des Parathormons und des Serumkalziums möglich. Beim primären und tertiären Hyperparathyreoidismus kommt es durch eine Übersekretion von Parathormon (PTH) zu einer Hyperkalzämie, beim sekundären Hyperparathyreoidismus versuchen die Nebenschilddrüsen, durch eine Erhöhung der PTH-Sekretion einen Kalzium oder Vitamin-D-Mangel auszugleichen – hier ist das Serumkalzium erniedrigt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 229.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur Kap. 3

  1. Bilezikian JP, Silverberg SJ (2003) Primary hyperparathyroidism. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 5th ed. American Society for Bone and Mineral Research, Washington, DC, pp 230–234

    Google Scholar 

  2. Meryl S et al. (2003) Hypercalcemia: clinical manifestations, pathogenesis, diagnosis, and management. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 5th ed. American Society for Bone and Mineral Research, Washington, DC, pp 225–229

    Google Scholar 

  3. Pecherstorfer M et al. (1994) Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients. J Clin Endocrinol Metab 78:1268–1270

    PubMed  CAS  Google Scholar 

  4. Schilling T et al. (1993) Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy. J Clin Endocrinol Metab 76:801–803

    PubMed  CAS  Google Scholar 

  5. Schipani E et al. (1996) Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen’s metaphyseal chondrodysplasia. N Engl J Med 335:708–714

    PubMed  CAS  Google Scholar 

  6. Wook J (2010) Fluid and electrolyte disturbances in critically ill patients. Electrolyte Blood Press 8:72–81

    Google Scholar 

  7. Akerström G, Malmaeus J, Bergström R (1984) Surgical anatomy of human parathyroid glands. Surgery 95:14–21

    PubMed  Google Scholar 

  8. Altenähr E (1980) Entwicklungsgeschichte und Anatomie der Nebenschilddrüsen. In: Rothmund M (Hrsg) Hyperparathyreoidismus. Thieme, Stuttgart, S 104–111

    Google Scholar 

  9. Alveryd A (1968) Parathyroid glands in thyroid surgery. I. Anatomy of glands. II. Postoperative hypoparathyroidism – identification and autotransplantation of parathyroid glands. Acta Clin Scand 389:1–120

    CAS  Google Scholar 

  10. Bargmann W (1939) Die Epithelkörperchen. In: Möllendorff W von (Hrsg) Handbuch der mikroskopischen Anatomie des Menschen, Bd VIf/2. Springer, Berlin, S 137–196

    Google Scholar 

  11. Bartsch D, Nies C, Hasse C et al. (1995) Clinical and surgical aspects of double adenoma in patients with primary hyperparathyroidism. Br J Surg 82:926–929

    PubMed  CAS  Google Scholar 

  12. Doppman JL, Marx SJ, Brennan MF, Beazley RM, Geelhoed G et al. (1977) The blood supply of mediastinal parathyroid adenomas. Ann Surg 185:488–490

    PubMed  CAS  Google Scholar 

  13. Edis AJ (1977) Surgical anatomy and technique of neck exploration for primary hyperparathyroidism. Surg Clin North Am 57:495–504

    PubMed  CAS  Google Scholar 

  14. Edis AJ, Beahrs OH, Heerden JA van, Akwari OE (1977) „Concervative“ versus „liberal“ approach to parathyroid neck exploration. Surgery 82:466–473

    PubMed  CAS  Google Scholar 

  15. Edis AJ, Purnell DC, Heerden JA van (1979) The undescended „parathymus“. An occasional cause of failed neck exploration for hyperparathyroidism. Ann Surg 190:64–68

    PubMed  CAS  Google Scholar 

  16. Gilmour JR (1938) The gross anatomy of the parathyroid glands. J Pathol 46:133–149

    Google Scholar 

  17. Gilmour JR, Martin WJ (1937) The weight of parathyroid glands. J Pathol 44:431–462

    Google Scholar 

  18. Halsted W, Evans H (1907) The parathyroid glandules. Their blood supply and their preservation in operation upon the thyroid gland. Ann Surg 46:489–506

    PubMed  CAS  Google Scholar 

  19. Nies C, Sitter H, Zielke A et al. (1994) Parathyroid function following ligation of the inferior thyroid arteries during bilateral subtotal thyroidectomy. Br J Surg 81:1757–1759

    PubMed  CAS  Google Scholar 

  20. Rothmund M, Wagner PK (1988) Reoperations for persistent and recurrent secondary hyperparathyroidism. Ann Surg 207:310–314

    PubMed  CAS  Google Scholar 

  21. Thompson NW (1986) Surgical anatomy of hyperparathyroidism. Prog Surg 18:59–79

    Google Scholar 

  22. Thompson NW, Eckhauser FE, Harness JK (1982) The anatomy of primary hyperparathyroidism. Surgery 92:814–821

    PubMed  CAS  Google Scholar 

  23. Wang CA (1976) The anatomic basis of parathyroid surgery. Ann Surg 183:271–275

    PubMed  CAS  Google Scholar 

  24. Wells SA, Leight GS, Hensley M, Dilley WD (1985) Hyperparathyroidism associated with the enlargement of two or three parathyroid glands. Ann Surg 202:533–538

    PubMed  Google Scholar 

  25. Albright F (1948) A page out of the history of parathyroidism. Endocrinol Metab Clin North Am 8:637–57

    CAS  Google Scholar 

  26. Albright F, Bloomberg E, Castleman B, Churchill ED (1934) Hyperparathyroidism due to a diffuse hyperplasia of all parathyroid glands rather than adenoma of one. Arch Intern Med 54:315–329

    Google Scholar 

  27. Altenähr E (1972) Ultrastructural pathology of parathyroid glands. Curr Top Pathol 56:1–54

    Google Scholar 

  28. Altenähr E (1980) Normale und pathologische Anatomie der NSD. In: Rothmund M (Hrsg) Hyperparathyreoidismus. Thieme, Stuttgart New York, S 112

    Google Scholar 

  29. Altenähr E, Dammann HJ (1971) Über Beziehungen zwischen Zelltyp und Kernstruktur in Epithelkörperchen. Virchows Arch A 352:111–121

    Google Scholar 

  30. Bargmann W (1939) Die Epithelkörperchen. In: Möllendorf W von (Hrsg) Handbuch der mikroskopischen Anatomie des Menschen, Bd. VI/2. Springer, Berlin, S 137–196

    Google Scholar 

  31. Bengtsson AL, Grimelius L, Johansson H, Ponten J (1977) Nuclear DNA-content of parathyroid cells in adenomas, hyperplastic, and normal glands. Acta Pathol Microbiol Scand 85:455–460

    CAS  Google Scholar 

  32. Billingsley KG, Fraker DL, Doppman JL et al. (1994) Localization and operative management of undescended parathyroid adenomas in patients with persistent primary hyperparathyroidism. Surgery 116:982–989

    PubMed  CAS  Google Scholar 

  33. Bondeson AG, Bondeson L, Thompson NW (1993) Clinicopathological peculiarities in parathyroid disease with hypercalcaemic crisis. Eur J Surg 159:613–617

    PubMed  CAS  Google Scholar 

  34. Brandi ML, Aurbach GD, Fitzpatrick LA et al. (1986) Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. N Engl J Med 314:1287–1293

    PubMed  CAS  Google Scholar 

  35. Carling T, Rastad J, Szabo E, Westin G, Akerstrom G (2000) Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. J Clin Endocinol Metab 85:2000–2003

    CAS  Google Scholar 

  36. Carling T (2001) Molecular pathology of parathyroid tumors. Trends Endocrinol Metab 12:23–28

    Google Scholar 

  37. Carlson D (2010) Parathyroid Pathology – Hyperparathyroidism and Parathyroid Tumors. Arch Pathol Lab Med 134:1639–1644

    PubMed  Google Scholar 

  38. Castleman B, Schantz SI, Roth SI (1976) Parathyroid hyperplasia in primary hyperparathyroidism. Review of 85 cases. Cancer 38:1668–1675

    PubMed  CAS  Google Scholar 

  39. Chattopadhaya N, Mithal A, Brown EM(1996) The calcium-sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism. Endcor Rev 17:289–307

    Google Scholar 

  40. Chen RA, Goodman WG (2004) Role of the calcium-sensing receptor in parathyroid gland physiology. Am J Physiol Renal Physiol 286:F1005–1011

    PubMed  CAS  Google Scholar 

  41. Cohn DV, Hamilton JW (1976) Newer aspect of parathyroid chemistry and physiology. Cornell Vet 66:271

    PubMed  CAS  Google Scholar 

  42. Cope OW, Keynes WM, Roth SI, Castleman B (1958) Primary chief cell-hyperplasia of the parathyroid glands: a new entity in the surgery of hyperparathyroidism. Ann Surg 148:375–388

    PubMed  CAS  Google Scholar 

  43. DeLellis RA, Dayal Y, Tischler AS, Lee AK, Wolfe HJ (1986) Multiple endocrine neoplasia (MEN) syndromes: cellular origins and interrelationships. Int Rev Exp Pathol 28:163–215

    PubMed  CAS  Google Scholar 

  44. Dietel M (1982) Functional morphology and pathology of parathyroid glands. Fischer, Stuttgart

    Google Scholar 

  45. Dietel M, Altenähr E (1981) Distribution of PTH in normal and pathological parathyroid glands. An immunohistochemical study. Acta Endocrinol (Copenh) 96:27–28

    Google Scholar 

  46. Dietel M, Hölzel F (1983) Influence on parathyroid hormone storage in normal and adenomatous parathyroid tissue by stimulation and inhibition in vitro. J Histochem Cytochem 31:275–284

    PubMed  CAS  Google Scholar 

  47. Dietel M, Dorn G, Montz R, Altenähr E (1979) Influence of vitamin D3, 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion, adenosine 3’,5’-monophosphate release, and ultrastructure of parathyroid glands in organe culture. Endocrinology 105:237–245

    PubMed  CAS  Google Scholar 

  48. Dietel M, Arps H, Niendorf A, Schäfer H-J, Hölzel F (1987) Abnormal calcium distribution in human parathyroid adenomas as possible cause of primary hyperparathyroidism. Horm Metab Res 19:177–181

    PubMed  CAS  Google Scholar 

  49. Dorado AE, Hensley G, Castleman B (1976) Water clear cell hyperplasia of parathyroid – autopsy report of a case with supernumerary glands. Cancer 38:1676–1683

    PubMed  CAS  Google Scholar 

  50. Dubost C, Jehanno C, Lavergne A, Le Charpentier Y (1984) Successful resection of intrathoracic metastases from two patients with parathyroid carcinoma. World J Surg 8:547

    PubMed  CAS  Google Scholar 

  51. Fraglia RA, Nassar VH, Dagher F, Salti IS (1972) Familial parathyroid carcinoma. J Med Liban 25:299–309

    Google Scholar 

  52. Fraser WD (2009) Hyperparathyroidism. Lancet 374:145–158

    PubMed  CAS  Google Scholar 

  53. Gilmour JR (1937) The embryology of the parathyroid glands, the thymus, and certain associated rudiments. J Pathol Bacteriol 45:502—522

    Google Scholar 

  54. Hendy GM (2000) Molecular mechanisms of primary hyperparathyroidism. Rev Endcor Metab Disord 1:297–305

    CAS  Google Scholar 

  55. Janson KL, Roberts JA, Varela M (1978) Multiple endocrine adenomatosis: in support of the common origin theories. J Urol 119:161

    PubMed  CAS  Google Scholar 

  56. Johnson S (2010) Changing clinicopathological practice in parathyroid disease Histopathology 56:835–851

    PubMed  Google Scholar 

  57. Kifor O, Moore FD Jr, Wang P, Goldstein M, Vassilev P, Kifor I, Hebert SC, Brown EM (1996) Reduced immunostaining for the extracellular Ca 2+-sensing receptor in primary an uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81:1598–1606

    PubMed  CAS  Google Scholar 

  58. Leana-Cox J, Pangkanon S, Eanet KR, Curtin MS, Wulfsberg EA (1996) Familial DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2: report of five families with a review of the literature. J Med Genet 65:309–316

    CAS  Google Scholar 

  59. LeGolvan DP, Moore BP, Nishiyama RH (1977) Parathyroid hamartoma. Report of two cases and review of the literature. Am J Clin Pathol 67:31–35

    PubMed  CAS  Google Scholar 

  60. Marx JS, Fedak SA, Aurbach GD (1972) Preparation and characterization of a hormone-responsive renal plasma membrane fraction. J Biol Chem 247:6913

    PubMed  CAS  Google Scholar 

  61. Marx SJ (2005) Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nature Reviews Cancer 5: 367–375

    PubMed  CAS  Google Scholar 

  62. Moseley JM, Kubota M, Diefenbach-Jagger H et al. (1987) Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 84:5048–5050

    PubMed  CAS  Google Scholar 

  63. Nordenstrom J, Strigard K, Perbeck L, Willems J, Bagedahl-Strindlund M, Linder J (1992) Hyperparathyroidism associated with treatment of manic-depressive disorders by lithium. Eur J Surg 158:207–211

    PubMed  CAS  Google Scholar 

  64. Pearse AGE (1975) Neurocristopathy, neuroendocrine pathology and the APUD concept. Z Krebsforsch 84:1–18

    CAS  Google Scholar 

  65. Perosio P, Brooks JJ, LiVolsi VA (1988) Orbital brown tumor as the initial manifestation of parathyroid lipoadenoma. Surg Pathol 1:77–82

    Google Scholar 

  66. Rasmussen H (1968) The parathyroids. In: Williams R (ed) Textbook of endocrinology. Saunders, Philadelphia, p 922

    Google Scholar 

  67. Raue F, Gagel RF (1989) Multiple endokrine Neoplasie. In: Hesch RD (Hrsg) Endokrinologie. Urban & Schwarzenberg, München Wien Baltimore, S 1109

    Google Scholar 

  68. Reddick RL, Costa JC, Marx SJ (1977) Parathyroid hyperplasia and parathyromatosis [letter]. Lancet 1:549

    PubMed  CAS  Google Scholar 

  69. Rosai J (2004) Parathyroid glands. In: Rosai J. Rosai and Ackerman’s Surgical Pathology (eds) 9th ed., New York, pp 595–619

    Google Scholar 

  70. Roth SI (1970) The ultrastructure of primary water-clear cell hyperplasia of the parathyroid glands. Am J Pathol 61:233–248

    PubMed  CAS  Google Scholar 

  71. Roth SI, Gallagher MJ (1976) The rapid identification of abnormal parathyroid glands by the presence of intracellular fat. Am J Pathol 84:521–527

    PubMed  CAS  Google Scholar 

  72. Rothmund M (1980) Operative Behandlung des sekundären Hyperparathyreoidismus. In: Rothmund M (Hrsg) Hyperparathyreoidismus. Thieme, Stuttgart New York, S 234–246

    Google Scholar 

  73. Sandström J (1879-80) On a new gland in man and several mammals (glandulae parathyreoideae). Ups Läk Fören Förh 15:441

    Google Scholar 

  74. Schachner SH, Riley TR, Old JW, Taft DA, Hamwi GJ (1966) Familial hyperparathyroidism. Arch Intern Med 117:417–422

    Google Scholar 

  75. Schantz A, Castleman B (1973) Parathyroid carcinomas: a study of 70 cases. Cancer 31:600

    PubMed  CAS  Google Scholar 

  76. Sharretts JM, Simonds WF (2010) Clinical and molecular genetics of parathyroid neoplasms Best Practice & Research Clinical Endocrinology & Metabolism 24:491–502

    CAS  Google Scholar 

  77. Suva LJ, Winslow G, Wettenhall R et al. (1987) A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237:893–895

    PubMed  CAS  Google Scholar 

  78. Bilezikian JP, Khan AA, Potts JT on behalf of the Third International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94:335–339

    PubMed  CAS  Google Scholar 

  79. Mahadevia PJ, Sosa JA, Levine MA et al. (2003) Clinical management of primary hyperparathyroidism andthresholds for surgical referral: a national study examining concordance between practice patterns and consensus panel recommendations. Endocr Pract 9:494–503

    PubMed  Google Scholar 

  80. Selby P (2011) Asymptomatic primary hyperparathyroidism – we have half the answers. Clin Endocrinol 75:156–157

    Google Scholar 

  81. Silverberg SJ, Shane E, Jacobs TP et al. (1990) Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 89:327–334

    PubMed  CAS  Google Scholar 

  82. Solomon BL, Schaaf M, Smallridge RC (1994) Psychologic symptoms before and after parathyroid surgery. Am J Med 96:101–106

    PubMed  CAS  Google Scholar 

  83. Sywak MS, Knowlton ST, Pasieka JL et al. (2002) Do the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism? Surgery 132:1013–1019

    PubMed  Google Scholar 

  84. Wermers RA, Khosla S, Atkinson EJ et al. (1997) The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965–1992. Ann Intern Med 126:433–440

    PubMed  CAS  Google Scholar 

  85. Bilezikian JP, Khan AA, Potts JT jr (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94:335–339

    PubMed  CAS  Google Scholar 

  86. Blind E (1997) Introduction to the use of intact parathyroid hormone (PTH) determination. In: Schmidt-Gayk H, Blind E, Roth HJ (eds) Calcium regulating hormones and markers of bone metabolism: measurement and interpretation. Clin Lab Publications, Heidelberg

    Google Scholar 

  87. Blind E, Raue F (2005) Parathormon-related protein (PTHrP). In: Thomas L (Hrsg) Labor und Diagnose. TH-Books, Frankfurt, pp 361–364

    Google Scholar 

  88. Blind E (2008) Twenty years of progress with parathyroid hormone (PTH): from specialized and „difficult“ measurement to common laboratory parameter and treatment option in osteoporosis. Clin Lab 54:439–449

    PubMed  CAS  Google Scholar 

  89. Carnevale V, Dionisi S, Nofroni I, Romagnoli E, Paglia F, De Geronimo S, Pepe J, Clemente G, Tonnarini G, Minisola S (2004) Potential clinical utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism. Clin Chem 50:626–631

    PubMed  CAS  Google Scholar 

  90. El-Hajj Fuleihan G (2002) Familial benign hypocalciuric hypercalcemia. J Bone Miner Res 17 (Suppl 2):N51–56

    Google Scholar 

  91. Gao P, Scheibel S, D’AmourP, John MR, Rao SD, Schmidt-Gayk H, Cantor TL (2001) Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1–84: Implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16:605–614

    PubMed  CAS  Google Scholar 

  92. Jüppner H, Potts JT Jr (2002) Immunoassays for the detection of parathyroid hormone. J Bone Miner Res 17 (Suppl 2):N81–86

    PubMed  Google Scholar 

  93. Pfeilschifter J, Schatz H (2000) Differentialdiagnose der Hyperkalzämie bei Erwachsenen. Med Klin 95:143–150

    CAS  Google Scholar 

  94. Ventz M, Quinkler M (2010) Primärer Hyperparathyreoidismus. Dtsch Med Wochenschr 135:2024–2030

    PubMed  Google Scholar 

  95. Adams JE, Adams PH, Mamtora H, Isherhodd I (1981) Computed tomography and localization of parathyroid tumors. Clin Radiol 32: 720–726

    Google Scholar 

  96. Altenvoerde A, Sahlmann CO, Altenvoerde G, Lehmann K, Meller J (2004) Diagnostischer Zugewinn durch iterativ rekonstruierte SPECT bei er Nebenschilddrüsen-Szintigraphie mit Tc-99 m-MIBI. Nuclear Med 43:A140

    Google Scholar 

  97. Auffermann W, Gooding GA, Okerlund MD et al. (1988) Diagnosis of recurrent hyperparathyroidism: comparison of MR imaging and other imaging techniques. Am J Roentgenol 150:1027–1033

    CAS  Google Scholar 

  98. Calva-Cerqueira D, Smith BJ, Hostetler ML, Lal G, Menda Y, O’Dorisio TM, Howe JR (2007) Minimally invasive parathyroidectomy and preoperative MIBI scans: correlation of gland weight and preoperative PTH. J Am Coll Surg 205:S38–44

    PubMed  Google Scholar 

  99. Cavaco BM, Torrinha F, Mendonca E, Pratas S, Boavida J, Sobrinho LG, Leite V (2003). Preoperative diagnosis of suspicious parathyroid adenomas by RT-PCR using mRNA extracted from leftover cells in a needle used for ultrasonically guided fine needle aspiration cytology. Acta Cytol 47: 5–12

    PubMed  Google Scholar 

  100. Doppman JL (1976) Parathyroid localization: arteriography and venous sampling. Radiol Clin North Am 14:163–188

    PubMed  CAS  Google Scholar 

  101. Fayet P, Hoeffel C, Fulla Y, Legmann P, Hazebroucq V, Luton JP, Chapuis Y, Richard B, Bonnin A (1997) Technetium-99 m-sestamibi scintigraphy, magnetic resonance imaging and venous blodd sampling in persistent and recurrent hyperparathyroidism. Br J Radiol 70:459–464

    PubMed  CAS  Google Scholar 

  102. Friedman K, Somervell H, Patel P, Melton GB, Garrett-Mayer E, Dackiw AP, Civelek AC, Zeiger MA (2004) Effect of calcium channel blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism. Surgery 136:1199–1204

    PubMed  Google Scholar 

  103. Ghaberi BA, Koslin DB, Wood AH, Cohen JL (2004) Preoperative ultrasound is worthwhile for reoperative parathyroid surgery. Laryngoscope 114:2168–2171

    Google Scholar 

  104. Gotthardt M, Lohmann B, Behr TM, Bauhofer A, Franzius C, Schipper ML, Wagner M, Höffken H, Sitter H, Rothmund M, Jospeh K, Nies C (2004a) Clinical value of parathyroid scintigraphy with Technetium-99 m- Methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature. World J Surg 28:100–107

    PubMed  Google Scholar 

  105. Gotthardt M, Sieber V, Zielke A, Karakas E, Heinis J, Höffken H, Behr TM (2004b) Ergebnisse der Nebenschilddrüsenszintigaphie mit 99mTc-MIBI: Einfluss von Schilddrüsengröße, Schilddrüsenknoten und SPECT. Nuklearmedizin 43:140

    Google Scholar 

  106. Gotway MB, Higgins CB (2000) MR imaging of the thyroid and parathyroid glands. Magn Reson Imaging Clin N Am 8:163–182

    PubMed  CAS  Google Scholar 

  107. Gotway MB, Reddy GP, Webb WR, Morita ET, Clark OH, Higgins CB (2001) Comparison between MR imaging and 99mTC MIBI scintigraphy in the evaluation of recurrent or persistent hyperparathyroidism. Radiology 218:783–790

    PubMed  CAS  Google Scholar 

  108. Gotway MB, Leung JWT, Gooding GA, Reddy GP, Morita ET, Webb WR, Clark OH, Higgins CB (2002) Hyperfunctioning parathyroid tissue: spectrum of appearances on non-invasive imaging. Amer J Roentgenol 179:495–502

    Google Scholar 

  109. Hajioff D, Iyngkaran T, Panagamuwa C, Hill D, Stearns MP (2004) Preoperative localization of parathyroid adenomas: ultrasonography, sestamibi scintigraphy, or both? Clin Otolaryngol 29:549–552

    PubMed  CAS  Google Scholar 

  110. Jones JJ, Brunaud L, Dowd CF, Duh QY, Morita E, Clark OH (2002) Accuracy of selective venous sampling for intact parathyroid hormone in difficult patients with recurrent or persistent hyperparathyroidism. Surgery 132:944–951

    PubMed  Google Scholar 

  111. Kandil E, Tufaro AP, Carson KA, Lin F, Somervell H, Farrag T, Dackiw A, Zeiger M, Tufano RP (2008) Correlation of plasma 25-hydroxyvitamin D levels with severity of primary hyperparathyroidism and likelihood of parathyroid adenoma localization on sestamibi scan. Arch Otolaryngol Head Neck Surg 134:1071–1075

    PubMed  Google Scholar 

  112. Karakas E, Zielke A, Dietz C, Rothmund M (2005) Reoperationen beim primären Hyperparathyreoidismus. Erfahrungen aus der Literatur und 106 eigenen Reoperationen. Chirurg 76:207–216

    PubMed  CAS  Google Scholar 

  113. Kebapci M, Entok E, Kebapci N, Adapinar B (2004) Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease:role of high resolution ultrasonography and dual phase technetium 99 m sestamibi scintigraphy. J Endocrinol Invest 27:24–30

    PubMed  CAS  Google Scholar 

  114. Levine DS, Belzberg AS, Wiseman SM (2009) Hybrid SPECT/CT imaging for primary hyperparathyroidism. Clin Nucl Med 34: 779–784

    PubMed  Google Scholar 

  115. Martin RCG, Greenwell D, Flynn MB (2000) Initial neck exploration for untreated hyperparathyroidism. Am Surg 66:269–272

    PubMed  Google Scholar 

  116. Nies C (2004) Primary hyperparathyroidism: is there a role for imaging? Eur J Nucl Med Mol Imag 31:1324–1326

    Google Scholar 

  117. Numerow IM, Morita ET, Clark OH, Higgins CB (1995) Persistent/recurrent hyperparathroidism: a comparison of sestamibi scintigraphy, MRI, and ultrasonography. J Magn Reson Imaging 5:702–708

    PubMed  CAS  Google Scholar 

  118. Otto D, Boerner AR, Hofmann M, Brunkhorst T, Meyer GJ, Petrich T, Scheumann GF, Knapp WH (2004) Pre-operative localisation of hyperfunctional parathyroid tissue with 11 C-methionine PET Eur J Nucl Med Mol Imaging 31:1405–1412

    PubMed  CAS  Google Scholar 

  119. Patel CN, Scarsbrook AF (2009) Multimodality imaging in hyperparathyroidism. Postgrad Med 85: 597-605

    CAS  Google Scholar 

  120. Rodgers SE, Hunter GJ, Hamberg LM, Schellingerhout D, Doherty DB, Ayers GD, Shapiro SE, Edeiken BS, Truong MT, Evans DB, Lee JE, Perrier ND (2006) Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery 140:932–941

    PubMed  Google Scholar 

  121. Peck WW, Higgins CB, Fisher MR, Ling M, Okerlund MD, Clark OH (1987) Hyperparathyroidism: comparison of MR imaging with radionuclide scanning. Radiology 163:415–420

    PubMed  CAS  Google Scholar 

  122. Schommartz B, Cupisti K, Antike C, Schmidt D, Knoefel W-T, Müller H-W (2006) Lokalisation von Nebenschilddrüsenadenomen mit planerer 99mTc-Sestamibi-Szintigraphie: Vergleich von Subtraktions- und 2-Phasen-Technik. Nuklearmedizin 45:115–121

    PubMed  CAS  Google Scholar 

  123. Siperstein A, Berber E, Mackey R, Alghoul M, Wagner K, Milas M (2004) Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperthyroidism. Surgery 136:872–880

    PubMed  Google Scholar 

  124. Siperstein A, Berber E, Barbosa GF, Tsinberg M, Greene AB, Mitchell J, Milas M (2008) Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg 248:420–428

    PubMed  Google Scholar 

  125. Taillefer R, Boucher Y, Potvoiuc C, Lambert R (1992) Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with 99mTc-sestamibi (double phase study). J Nucl Med 33:1891–1897

    Google Scholar 

  126. Tseng FY, Hsiao YL, Chang TC (2002) Ultrasound-guided fine needle aspiration cytology of parathyroid lesions. A review of 72 cases. Acta Cytol 46:1029–1036

    PubMed  Google Scholar 

  127. Walgenbach S, Dutkowski P, Andreas J et al. (1999) 99mTc-MIBI Szintigraphie vor Eingriffen wegen Hyperparathyreoidismus? Zentralblatt f Chirurgie 124:214–219

    CAS  Google Scholar 

  128. Akerström G, Malmaeus J, Bergström R (1984) Surgical anatomy of human parathyroid glands. Surgery 95:14–21

    PubMed  Google Scholar 

  129. Almquist EG, Becker C, Bondeson AG, Bondeson L et al. (2004) Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: prospective randomized study. Surgery 136:1281–1288

    Google Scholar 

  130. Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J (2002) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 236:543–551

    PubMed  Google Scholar 

  131. Bergenfelz A, Kanngiesser V, Zielke A, Nies C, Rothmund M (2005) Conventional bilateral cervical exploration versus open minimally invasive parathyroidectomy under local anaesthesia for primary hyperparathyroidism. Br J Surg 92:190–197

    PubMed  CAS  Google Scholar 

  132. Bilezikian JP, Potts JT Jr, Fuleihan G,Kleerekoper M et al. (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidisma perspective for the 21st century. J Clin Endocrinol Metab 87:5353–5361

    PubMed  CAS  Google Scholar 

  133. Bilezikian JP, Khan A., Potts J et al. (2009) Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop. J Clin Endocrinol Metab 94:335–339

    PubMed  CAS  Google Scholar 

  134. Carneiro DL, Solorzano,CC, Irvin GL (2004) Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism. J Am Coll Surg 199:849–855

    PubMed  Google Scholar 

  135. Caron NR, Pasieka JL (2009) What symptom improvement can be expected after operation for primary hyperparathyroidism?. World J Surg 33:2244–2255

    PubMed  Google Scholar 

  136. Chapuis Y, Fulla Y, Icard P et al. (1990) Peroperative assay of active parathormone 1-84 in surgery of primary hyperparathyreoidism. Press Med 19:1461–1462

    CAS  Google Scholar 

  137. Chapuis Y, Icard P, Fulla Y, Nonnenmacher L et al. (1992) Parathyroid adenomectomy under local anesthesia with intra-operative monitoring of UcAMP and/or 1-84 PTH. World J Surg 16:570–575

    PubMed  CAS  Google Scholar 

  138. Chen H, Sokoll LJ, Udelsman R (1999) Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery 126:1016–1021

    PubMed  CAS  Google Scholar 

  139. Chen H, Wang TS, Yen TW, Doffek K, Krzywda E et al. (2010) Operative failures after parathyroidectomy for hyperparathyroidism: the influence of surgical volume. Ann Surg 252:691–695

    PubMed  Google Scholar 

  140. Clerici T, Brandle M, Lange J, Doherty GM et al. (2004) Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease. World J Surg 28:187–192

    PubMed  Google Scholar 

  141. Eigelberger MS, Cheah WK, Ituarte PH, Streja L et al. (2004) The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann Surg 239:528–535

    PubMed  Google Scholar 

  142. Elaraj DM, Skarulis MC, Libutti SK, Norton JA, Bartlett DL, Pingpank JF, Gibril F, Weinstein LS, Jensen RT, Marx SJ, Alexander HR (2003) Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery 134:858–864

    PubMed  Google Scholar 

  143. Funke M, Kim M, Hasse Ch, Bartsch D, Rothmund M (1997) Ergebnisse eines standardisierten Therapiekonzepts bei primärem Hyperparathyreoidismus. Dtsch Med Wochenschr 122:1475–1481

    PubMed  CAS  Google Scholar 

  144. Gagner M (1996) Endoscopic subtotal parathyroidectomy in patients with primary hyperparathyroidism. Br J Surg 83:875

    PubMed  CAS  Google Scholar 

  145. Gauger PG, Agerwal G, England BG, Delbridge LW et al. (2001) Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience. Surgery 130:1005–1010

    PubMed  CAS  Google Scholar 

  146. Harrison B, Triponez F (2009) Intraoperative adjuncts in surgery for primary hyperparathyroidism. Langenbecks Arch Surg 394:799–809

    PubMed  Google Scholar 

  147. Hasse C, Sitter H, Bachmann S, Zielke A et al. (2000) How asymptomatic is asymptomatic primary hyperparathyroidism? Exp Clin Endocrinol Diabetes 108:265–274

    PubMed  CAS  Google Scholar 

  148. Hedback GM, Oden AS (2002) Cardiovascular disease, hypertension and renal function in primary hyperparathyroidism. J.Intern.Med. 251:476–483

    PubMed  CAS  Google Scholar 

  149. Henry JF, Defechereux T, Gramatica L, de Boissezon C (1999) Minimally invasive videoscopic parathyroidectomy by lateral approach. Langenbecks Arch Surg 384:298–301

    PubMed  CAS  Google Scholar 

  150. Henry JF, Sebag F, Tamagnini P, Forman C et al. (2004) Endosopic parathyroid surgery: results of 365 conseutive procedures. World J Surg 28:1219–1223

    PubMed  Google Scholar 

  151. Irvin GL, Dembrow VD, Prudhomme DL (1991) Operative monitoring of parathyroid gland hyperfunction. Am J Surg 162:299–302

    PubMed  Google Scholar 

  152. Irvin GL, Deriso GT (1994) A new, practical intraoperative parathyroid hormone assay. Am J Surg 168:466–468

    PubMed  Google Scholar 

  153. Irvin GL, Molinari AS, Figueroa C, Carneiro DM (1999) Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg 229:874–879

    PubMed  Google Scholar 

  154. Lundgren E, Rastad J, Thurfjell E, Akerström G et al. (1997) Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 121:287–294

    PubMed  CAS  Google Scholar 

  155. Lombardi CP, Raffaelli M, Traini E, Di Stasio E, Carrozza C, De Crea C, Zuppi C, Bellantone R (2008) Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease. Langenbecks Arch.Surg 393:639–645

    PubMed  Google Scholar 

  156. Lorenz K, Dralle H (2010) [Intraoperative parathyroid hormone determination for primary hyperparathyroidism] Intraoperative Parathormonbestimmung beim primaren Hyperparathyreoidismus. Chirurg 81:636, 638–636, 642

    PubMed  CAS  Google Scholar 

  157. Malmaeus J, Granberg PO, Halvorsen G, Akerström G et al. (1988) Parathyroid surgery in Scandinavia. Acta Chir Scand 154:409–413

    PubMed  CAS  Google Scholar 

  158. Mandl F. (1933) Zur Technik der Parathyreoidectomie bei Osteitis fibrosa aufgrund neuerer Beobachtungen. Dtsch Z Chir 240:362

    Google Scholar 

  159. Mazzaglia PJ, Milas M, Berber E, Siperstein A, Monchik JM (2010) Normalization of 2-week postoperative parathyroid hormone values in patients with primary hyperparathyroidism: four-gland exploration compared to focused-approach surgery. World J Surg 34:1318–1324

    PubMed  Google Scholar 

  160. Miccoli P, Bendinelli C, Berti P, Vignali E et al. (1999) Video-assisted versus conventional parathyroidectomy in primary hyperparathyroidism: a prospective randomized study. Surgery 126:1117–1121

    PubMed  CAS  Google Scholar 

  161. Miccoli P, Berti P, Materazzi G, Massi M et al. (2004) Results of video-assisted parathyroidectomy: single institution’s six-year experience. World J Surg 28:1216–1218

    PubMed  Google Scholar 

  162. Miccoli P, Pinchera A, Cecchini G, Conte M et al. (1997) Minimally invasive, video-assisted parathyroid surgery for primary hyperparathyroidism. J Endocrinol Invest 20:429–430

    PubMed  CAS  Google Scholar 

  163. Mihai R, Palazzo FF, Gleeson FV, Sadler GP (2007) Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism. Br.J Surg 94:42–47

    PubMed  CAS  Google Scholar 

  164. Miller BS, England BG, Nehs M, Burney RE, Doherty GM, Gauger PG (2006) Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of <100 pg/mL. Surgery 140:883–890

    PubMed  Google Scholar 

  165. Morris GS, Grubbs EG, Hearon CM, Gantela S, Lee JE, Evans DB, Holmes HM, Busaidy NL, Jimenez C, Perrier ND (2010) Parathyroidectomy improves functional capacity in „asymptomatic“ older patients with primary hyperparathyroidism: a randomized control trial. Ann.Surg. 251:832–837

    PubMed  Google Scholar 

  166. Niederle B, Roka R, Fritsch A (1986) Long-term results after surgical treatment of primary hyperparathyroidism. In: Rothmund M, Wells SA (eds) Parathyroid surgery. Prog Surg 18:146–164

    Google Scholar 

  167. Nilsson IL (2004) Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease. Surgery 136:981

    PubMed  Google Scholar 

  168. Nilsson IL, Aberg J,Rastad J,Lind L (2000) Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy. Surgery 128:895–902

    PubMed  CAS  Google Scholar 

  169. Øgard CG,Engholm G, Almdal TP, Vestergaard H(2004) Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977–1993 in Denmark. World J Surg 28:108–111

    PubMed  Google Scholar 

  170. O Riordain DS, O Brien T, Grant CS, Weaver A, Gharib H, van HJA (1993) Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2. Surgery 114:1031–1037

    Google Scholar 

  171. Riss P, Kaczirek K, Heinz G, Bieglmayer C, Niederle B (2007) A „defined baseline“ in PTH monitoring increases surgical success in patients with multiple gland disease. Surgery 142:398–404

    PubMed  Google Scholar 

  172. Riss P, Scheuba C, Asari R, Bieglmayer C, Niederle B (2009) Is minimally invasive parathyroidectomy without QPTH monitoring justified? Langenbecks Arch.Surg 394:875–880

    PubMed  Google Scholar 

  173. Rudberg C, Akerstrom G, Palmer M, Ljunghall S, Adami HO, Johansson H, Grimelius L, Thoren L, Bergstrom R (1986) Late results of operation for primary hyperparathyroidism in 441 patients. Surgery 99:643–651

    PubMed  CAS  Google Scholar 

  174. Silverberg SJ, Gartenberg F, Jacobs ThP, Shane E et al. (1995) Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 80:729–734

    PubMed  CAS  Google Scholar 

  175. Silverberg SJ, Shane E, Jacobs TP, Siris E et al. (1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. New England J Med 341:1249

    CAS  Google Scholar 

  176. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR (2009) Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop. J Clin Endocrinol Metab 94:351–365

    PubMed  CAS  Google Scholar 

  177. Sitges-Serra A, Garcia L, Prieto R, Pena MJ, Nogues X, Sancho JJ (2010) Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women. Br J Surg 97:1013–1019

    PubMed  CAS  Google Scholar 

  178. Sywak MS, Knowlton ST, Pasieka JL,Parsons LL et al. (2002) Do the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism? Surgery 132:1013–1019

    PubMed  Google Scholar 

  179. Talpos GB, Bone HG, Kleerekoper M, Phillips ER et al. (2000) Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery 128:1013–1021

    PubMed  CAS  Google Scholar 

  180. Tibblin S, Bondeson AG, Ljungberg O (1982) Unilateral parathyroidectomy in hyperparathyreoidism due to a single adenoma. Ann Surg 195:245–252

    PubMed  CAS  Google Scholar 

  181. Udelsman R (2002) Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 235:665–672

    PubMed  Google Scholar 

  182. Udelsman R, Donovan PI (2004) Open minimally invasive parathyroid surgery. World J Surg 28:1224–1226

    PubMed  Google Scholar 

  183. Udelsman R, Lin Z, Donovan P (2011) The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 253:585–591

    PubMed  Google Scholar 

  184. VanderWalde LH, Liu IL, Haigh PI (2009) Effect of bone mineral density and parathyroidectomy on fracture risk in primary hyperparathyroidism. World J Surg 33:406–411

    PubMed  Google Scholar 

  185. Van Heerden JA, Grant CS (1991) Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg 15:688–692

    PubMed  Google Scholar 

  186. Vestergaard P, Mosekilde L (2003) Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ 327:530–534

    PubMed  Google Scholar 

  187. Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P et al. (2003) Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 27:216–222

    PubMed  Google Scholar 

  188. Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W (2009) Evaluation of Halle, Miami, Rome and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbecks Arch Surg 394: 843–849

    PubMed  Google Scholar 

  189. Bergenfelz A, Isaksson A, Ahren B (1994) Intraoperative monitoring of intact PTH during surgery for primary hyperparathyroidism. Langenbecks Arch Chir 379:50–53

    PubMed  CAS  Google Scholar 

  190. Bergenfelz A, Algotsson L, Roth B, Isaksson A et al. (1996) Side localization of parathyroid adenomas by simplified intraoperative venous sampling for parathyroid hormone. World J Surg 20:358–360

    PubMed  CAS  Google Scholar 

  191. Bergenfelz A, Isaksson A, Lindblom P, Westerdahl J et al. (1998) Measurement of parathyroid hormone in patients with primary hyperparathyroidism undergoing first and re-operative surgery. Br J Surg 85:221

    Google Scholar 

  192. Bilezikian JP, Khan AA, Potts JT (2009) Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the third International Group. J Endocrinol Metab 94:335–339

    CAS  Google Scholar 

  193. Billingsley KG, Fraker DL, Doppman JL, Norton JA et al. (1994) Localization and operative management of undescended parathyroid adenomas in patients with persistent primary hyperparathyroidism. Surgery 116:982–990

    PubMed  CAS  Google Scholar 

  194. Brennan MF, Norton JA (1985) Reoperation for persistent and recurrent hyperparathyroidism. Ann Surg 201:40–44

    PubMed  CAS  Google Scholar 

  195. Doherty GM, Doppman JL, Miller DL, Gee MS et al. (1992) Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidism. Ann Surg 215:101–106

    PubMed  CAS  Google Scholar 

  196. Doherty GM, Weber B, Norton JA (1994) Cost of unsuccessful surgery for primary hyperparathyroidism. Surgery 116:954–958

    PubMed  CAS  Google Scholar 

  197. Elaraj DM, Remaley AT, Simonds WF, Skarulis MC, Libutti SK, Bartlett DL, Venzon DJ, Marx SJ, Alexander HR (2002) Utility of rapid intraoperative parathyroid hormone assay to predict severe postoperative hypocalcemia after reoperation for hyperparahyroidism. Surgery 132:1028–1033

    PubMed  Google Scholar 

  198. Erbil Y, Salmashoglu A, Kabul E, Issever H et al. (2006) Use of preoperative fine-needle aspiration and parathormone assay in the primary hyperparathyroidism with concomitant thyroid nodules. Am J Surg 193:665–671

    Google Scholar 

  199. Fahy BN, Bold RJ, Beckett L, Schneider PD (2002) Modern Parathyroid surgery. A cost-benefit analysis of localization strategies. Arch Surg 137:917–923

    PubMed  Google Scholar 

  200. Funke M, Kim M, Hasse Ch, Bartsch D, Rothmund M (1997) Ergebnisse eines standardisierten Therapiekonzepts bei primärem Hyperparathyreoidismus. Dtsch Med Wochenschr 122:1475–1481

    PubMed  CAS  Google Scholar 

  201. Grant C S, Heerden JA van, Charboneau JW, James EM et al. (1986) Clinical management of persistent and/or recurrent primary hyperparathyroidism. World J Surg 10:555–565

    PubMed  CAS  Google Scholar 

  202. Hasse C, Sitter H, Brune M, Wollenteit I, Nies C, Rothmund M (2002) Quality of life and patient satisfaction after reoperation for primary hyperparathyroidism:analysis of long term results. World J Surg 26:1029–1036

    PubMed  Google Scholar 

  203. Hedbäck G, Oden A (2004) Persistent disease after surgery for primary hyperparathyroidism: the lon- term outcome. Eur J Endocrinol 150:19–25

    PubMed  Google Scholar 

  204. Heerden JA van (1997) American Association of Endocrine Surgeons Presidential address: lessons learned. Surgery 122:979–988

    PubMed  Google Scholar 

  205. Hessman O,, Stalberg P, Sundin A, Garske U, Rudberg C, Eriksson LG, Hellman P, Akerström G (2008) High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 32:774–781.

    PubMed  Google Scholar 

  206. Irvin GL 3rd, Molinari AS, Figueroa C, Carneiro DM (1999) Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg 229:874–878

    PubMed  Google Scholar 

  207. Jaskowiak N, Norton JA, Alexander HR et al. (1996) A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma. Ann Surg 224:308–322

    PubMed  CAS  Google Scholar 

  208. Karakas E, Zielke A, Dietz C, Rothmund M (2005) Reoperationen beim primären Hyperparathyreoidismus. Chirurg 76:207–216

    PubMed  CAS  Google Scholar 

  209. Karakas E, Schlosshauer T, Rothmund M, Bartsch DK (2012) Reoperations for primary hyperparathyroidism – does routine use of modern imaging and intraoperative PTH measurement improve results? Langenbecks Arch Surg (submitted)

    Google Scholar 

  210. Kiblut NK, Cussac JF, Soudan B, Farrell SG, Armstrong JA, Arnalsteen L, Biechlin A, Delattre AA, Proye CA (2004) Fine needle aspiration and intraparathyroid intact parathyroid hormone measurement for reoperative parathyroid surgery. World J Surg 28:1143–1147

    PubMed  Google Scholar 

  211. Kollmorgen CF, Aust MR, Ferreiro JA, McCarthy JT et al. (1994) Parathyromatosis: a rare yet important cause of persistent or recurrent hyperparathyroidism. Surgery 116:111–115

    PubMed  CAS  Google Scholar 

  212. Levin KE, Clark OH (1989) The reasons for failure in parathyroid operations. Arch Surg 124:911–917

    PubMed  CAS  Google Scholar 

  213. Libutti SK, Bartlett DL, Jaskowiak NT, Skarulis M et al. (1997) The role of thyroid resection during reoperation for persistent or recurrent hyperparathyroidism. Surgery 122:1183–1188

    PubMed  CAS  Google Scholar 

  214. Marx SJ, Stock LJ, Attie MF, Downs RW et al. (1980) Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration. Ann Intern Med 92:351–356

    PubMed  CAS  Google Scholar 

  215. McBiles M, Lambert AT, Cote MG, Kim SY (1995) Sestamibi parathyroid imaging. Nucl Med 25:221–234

    CAS  Google Scholar 

  216. Morris LF, Zanocco K, Ituarte PHG, Ro K, Duh QY et al. (2010) The value of intraoperative parathyroid hormone monitoring in localized primary hyperparathyroidism: a cost analysis. Ann Surg oncol 17:679–685

    PubMed  Google Scholar 

  217. Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD (1988) Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery 104:1121–1127

    PubMed  CAS  Google Scholar 

  218. Randone B, Costi R, Scatton O, Fulla Y, Bertagna X, Soubrane O, Bonnichon P (2010) Thoracoscopic reoval of mediastinal parathyroid glands A critical appraisal of an emerging technique. Ann Surg 251:717–721

    PubMed  Google Scholar 

  219. Richards ML, Thompson GB, Farley DR, Grant CS (2008) Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring. Am J Surg 196:937–943

    PubMed  Google Scholar 

  220. Udelsman R, Aruny JE, Donovan PI, Sokoll LJ, Santos F, Donabedian R, Venbrux AC. (2003) Rapid parathyroid hormone analysis during venous localization. World J Surg 237:714–719

    Google Scholar 

  221. Varghese J, Rich T, Jimenez C (2011) Benign familial hypocalciuric hypercalcemia. Endocr Pract 17:13–17

    PubMed  Google Scholar 

  222. Wagner PK, Seesko HG, Rothmund M (1991) Replantation of cryopreserved human parathyroid tissue. World J Surg 15:751–755

    PubMed  CAS  Google Scholar 

  223. Wang Ch (1977) Parathyroid re-exploration. A clinical and pathological study of 112 cases. Ann Surg 186:140–145

    PubMed  CAS  Google Scholar 

  224. Bilezikian JP, Khan AA, Potts JT jr (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94:335–339

    PubMed  CAS  Google Scholar 

  225. Chow CC, Chan WB, Li JK, Chan NN, Chan MH, Ko GT, Lo KW, Cockram CS (2003) Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 88:581–587

    PubMed  CAS  Google Scholar 

  226. Peacock M, Bilezikian JP, Bolognese MA, Borofsky M, Scumpia S, Sterling LR, Cheng S, Shoback D (2011) Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity. J Clin Endocrinol Metab 96:E9–18

    PubMed  CAS  Google Scholar 

  227. Steddon SJ, Cunningham J (2005) Calcimimetics and calcilytics – fooling the calcium receptor. Lancet 365:2237–2239

    PubMed  CAS  Google Scholar 

  228. Ahmad F, Strickland AD, Wright GM, Elabassy M, Kiruparan P, Bell PR, Lloyd DM (2005) Laparoscopic microwave tissue ablation of hepatic metastasis from a parathyroid carcinoma. Eur J Surg Oncol 31 (3):321–322

    PubMed  CAS  Google Scholar 

  229. Artinyan A, Guzman E, Maghami E, Al-Sayed M, D'Apuzzo M, Wagman L, Kim J (2008) Metastatic parathyroid carcinoma to the liver treated with radiofrequency ablation and transcatheter arterial embolization. J Clin Oncol 26 (24):4039-4041

    PubMed  Google Scholar 

  230. Betea D, Bradwell AR, Harvey TC, Mead GP, Schmidt-Gayk H, Ghaye B, Daly AF, Beckers A (2004) Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma. J Clin Endocrinol Metab 89 (7):3413–3420

    PubMed  CAS  Google Scholar 

  231. Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM, Jr., Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R (2004) Parathyroid carcinoma: a 22-year experience. Head Neck 26 (8):716–726

    Google Scholar 

  232. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Hoog A, Heath H, 3rd, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32 (4):676-680

    Google Scholar 

  233. Collins MT, Skarulis MC, Bilezikian JP, Silverberg SJ, Spiegel AM, Marx SJ (1998) Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab 83 (4):1083–1088

    PubMed  CAS  Google Scholar 

  234. de Francisco AL (2005) Cinacalcet HCl: a novel therapeutic for hyperparathyroidism. Expert Opin Pharmacother 6 (3):441–452

    PubMed  Google Scholar 

  235. DeLellis RA (2011) Parathyroid tumors and related disorders. Mod Pathol 24 Suppl 2:S78–93

    PubMed  CAS  Google Scholar 

  236. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual (7th ed). Springer, New York

    Google Scholar 

  237. Fang SH, Lal G (2011) Parathyroid cancer. Endocr Pract 17 Suppl 1:36–43

    PubMed  Google Scholar 

  238. Fujimoto Y, Obara T, Ito Y, Kanazawa K, Aiyoshi Y, Nobori M (1984) Surgical treatment of ten cases of parathyroid carcinoma: importance of an initial en bloc tumor resection. World J Surg 8 (3):392–400

    PubMed  CAS  Google Scholar 

  239. Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 86 (3):538–544

    PubMed  CAS  Google Scholar 

  240. Iacobone M, Lumachi F, Favia G (2004) Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases. J Surg Oncol 88 (4):223–228

    PubMed  Google Scholar 

  241. Kebebew E, Arici C, Duh QY, Clark OH (2001) Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg 136 (8):878–885

    PubMed  CAS  Google Scholar 

  242. Khan MW, Worcester EM, Straus FH, 2nd, Khan S, Staszak V, Kaplan EL (2004) Parathyroid carcinoma in secondary and tertiary hyperparathyroidism. J Am Coll Surg 199 (2):312–319

    PubMed  Google Scholar 

  243. Kirkby-Bott J, Lewis P, Harmer CL, Smellie WJ (2005) One stage treatment of parathyroid cancer. Eur J Surg Oncol 31 (1):78–83

    PubMed  CAS  Google Scholar 

  244. Koea JB, Shaw JH (1999) Parathyroid cancer: biology and management. Surg Oncol 8 (3):155–165

    PubMed  CAS  Google Scholar 

  245. Kulkarni PS, Parikh PM (2004) The carcinoma of parathyroid gland. Indian J Cancer 41 (2):51–59

    PubMed  CAS  Google Scholar 

  246. Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM (2007) Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 109 (9):1736–741

    PubMed  Google Scholar 

  247. Mittendorf EA, McHenry CR (2005) Parathyroid carcinoma. J Surg Oncol 89 (3):136–142

    PubMed  CAS  Google Scholar 

  248. Munson ND, Foote RL, Northcutt RC, Tiegs RD, Fitzpatrick LA, Grant CS, van Heerden JA, Thompson GB, Lloyd RV (2003) Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer 98 (11):2378–2384

    PubMed  Google Scholar 

  249. Obara T, Okamoto T, Ito Y, Yamashita T, Kawano M, Nishi T, Tani M, Sato K, Demura H, Fujimoto Y (1993) Surgical and medical management of patients with pulmonary metastasis from parathyroid carcinoma. Surgery 114 (6):1040–1048; discussion 1048–1049

    PubMed  CAS  Google Scholar 

  250. Okamoto T, Iihara M, Obara T, Tsukada T (2009) Parathyroid carcinoma: etiology, diagnosis, and treatment. World J Surg 33 (11):2343–2354

    PubMed  Google Scholar 

  251. Pichardo-Lowden AR, Manni A, Saunders BD, Baker MJ (2011) Familial Hyperparathyroidism Due to a Germline Mutation of the CDC73 gene: Implications for Management and Age-Appropriate Testing of Relatives at Risk. Endocr Pract:1–20

    PubMed  Google Scholar 

  252. Ruda JM, Hollenbeak CS, Stack BC, Jr. (2005) A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 132 (3):359–372

    PubMed  Google Scholar 

  253. Sainton P, Millot J (1933) Malegne d'un adenoma parathyroidiene eosinophile. Pathologique 10:813

    Google Scholar 

  254. Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO (1992) Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg 16 (4):724–731

    PubMed  CAS  Google Scholar 

  255. Sandelin K, Tullgren O, Farnebo LO (1994) Clinical course of metastatic parathyroid cancer. World J Surg 18 (4):594–598; discussion 599

    PubMed  CAS  Google Scholar 

  256. Sawady J, Mendelsohn G, Sirota RL, Taxy JB (1989) The intrathyroidal hyperfunctioning parathyroid gland. Mod Pathol 2 (6):652–657

    PubMed  CAS  Google Scholar 

  257. Schantz A, Castleman B (1973) Parathyroid carcinoma. A study of 70 cases. Cancer 31 (3):600–605

    PubMed  CAS  Google Scholar 

  258. Schott M, Feldkamp J, Schattenberg D, Krueger T, Dotzenrath C, Seissler J, Scherbaum WA (2000) Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate-pulsed dendritic cells. Eur J Endocrinol 142 (3):300–306

    PubMed  CAS  Google Scholar 

  259. Schulte KM, Talat N, Miell J, Moniz C, Sinha P, Diaz-Cano S (2010) Lymph node involvement and surgical approach in parathyroid cancer. World J Surg 34 (11):2611–2620

    PubMed  Google Scholar 

  260. Shaha AR, Shah JP (1999) Parathyroid carcinoma: a diagnostic and therapeutic challenge. Cancer 86 (3):378–380Shane E (2001) Clinical review 122: Parathyroid carcinoma. J Clin Endocrinol Metab 86 (2):485–493

    Google Scholar 

  261. Sharretts JM, Simonds WF (2010) Clinical and molecular genetics of parathyroid neoplasms. Best Pract Res Clin Endocrinol Metab 24 (3):491–502

    PubMed  CAS  Google Scholar 

  262. Sheu SY, Otterbach F, Frilling A, Schmid KW (2003) [Hyperplasia and tumors of the parathyroid glands]. Pathologe 24 (5):373–381

    PubMed  Google Scholar 

  263. Sidhu PS, Talat N, Patel P, Mulholland NJ, Schulte KM (2011) Ultrasound features of malignancy in the preoperative diagnosis of parathyroid cancer: a retrospective analysis of parathyroid tumours larger than 15 mm. Eur Radiol 21 (9):1865–1873

    PubMed  Google Scholar 

  264. Silverberg SJ, Rubin MR, Faiman C, Peacock M, Shoback DM, Smallridge RC, Schwanauer LE, Olson KA, Klassen P, Bilezikian JP (2007) Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 92 (10):3803–3808

    PubMed  CAS  Google Scholar 

  265. Solorzano CC, Carneiro-Pla DM, Lew JI, Rodgers SE, Montano R, Irvin GL, 3rd (2007) Intra-operative parathyroid hormone monitoring in patients with parathyroid cancer. Ann Surg Oncol 14 (11):3216–3222

    PubMed  CAS  Google Scholar 

  266. Talat N, Schulte KM (2010) Clinical presentation, staging and long-term evolution of parathyroid cancer. Ann Surg Oncol 17 (8):2156–2174

    PubMed  Google Scholar 

  267. Wilkins BJ, Lewis JS, Jr. (2009) Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery. Head Neck Pathol 3 (2):140–149

    PubMed  Google Scholar 

  268. Witteveen JE, Haak HR, Kievit J, Morreau H, Romijn JA, Hamdy NA (2010) Challenges and pitfalls in the management of parathyroid carcinoma: 17-year follow-up of a case and review of the literature. Horm Cancer 1 (4):205–214

    PubMed  Google Scholar 

  269. ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345–348

    Google Scholar 

  270. Arcidiacono MV, Sato T, Varez-Hernandez D, et al. (2008) EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease. J Am Soc Nephrol 19:310–320

    PubMed  CAS  Google Scholar 

  271. Arnold, A, Brown, MF, Urena, P, et al. (1995) Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95:2047–2053

    PubMed  CAS  Google Scholar 

  272. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, et al. (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003–4008

    PubMed  CAS  Google Scholar 

  273. Brown AJ, Ritter CS, Finch JL, et al. (1999) Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Kidney Int 55:1284–1292

    PubMed  CAS  Google Scholar 

  274. Brown AJ, Zhong M, Finch J, et al. (1996) Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol 270:F454–F460

    PubMed  CAS  Google Scholar 

  275. Brown EM, Gamba G, Riccardi D, et al. (1993) Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366:575–580

    PubMed  CAS  Google Scholar 

  276. Chudek J, Ritz E, Kovacs G (1998) Genetic abnormalities in parathyroid nodules of uremic patients. Clin Cancer Res 4:211–214

    PubMed  CAS  Google Scholar 

  277. Cozzolino M, Pasho S, Fallabrino G, et al. (2009) Pathogenesis of secondary hyperparathyroidism. Int J Artif Organs 32:75–80

    PubMed  CAS  Google Scholar 

  278. Dusso AS (2003) Vitamin D receptor: mechanisms for vitamin D resistance in renal failure Kidney Int Suppl:S6–S9

    Google Scholar 

  279. Dusso AS, Pavlopoulos T, Naumovich L, et al. (2001) p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth Kidney. Int 59:855–865

    CAS  Google Scholar 

  280. Dusso AS, Sato T, Arcidiacono MV, et al. (2006) Pathogenic mechanisms for parathyroid hyperplasia Kidney. Int Suppl:S8–11

    Google Scholar 

  281. Fraser DR, Kodicek, E (1970) Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature 228:764–766

    PubMed  CAS  Google Scholar 

  282. Fukuda N, Tanaka H, Tominaga Y, et al. (1993) Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436–1443

    PubMed  CAS  Google Scholar 

  283. Galitzer H, Ben-Dov IZ, Silver J, et al. (2010) Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 77:211–218

    PubMed  CAS  Google Scholar 

  284. Garfia B, Canadillas S, Canalejo A, et al. (2002) Regulation of parathyroid vitamin D receptor expression by extracellular calcium. J Am Soc Nephrol 13:2945–2952

    PubMed  CAS  Google Scholar 

  285. Godyn JJ, Xu H, Zhang F, et al. (1994) A dual block to cell cycle progression in HL60 cells exposed to analogues of vitamin D3. Cell Prolif 27:37–46

    PubMed  CAS  Google Scholar 

  286. Goodman WG, Quarles LD (2008) Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics. Kidney Int 74:276–288

    PubMed  CAS  Google Scholar 

  287. Goodman WG, Veldhuis JD, Belin, TR, et al. (1998) Calcium-sensing by parathyroid glands in secondary hyperparathyroidism. J Clin Endocrinol Metab 83:2765–2772

    PubMed  CAS  Google Scholar 

  288. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281

    PubMed  CAS  Google Scholar 

  289. Hsu CY, Chertow GM (2002) Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant 17:1419–1425

    PubMed  CAS  Google Scholar 

  290. Indridason OS, Heath H III, Khosla S, et al. (1996) Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism. Kidney Int 50:1663–1671

    PubMed  CAS  Google Scholar 

  291. Kifor O, Moore FD, Jr, Wang P, et al. (1996) Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism J Clin Endocrinol Metab 81:1598–1606

    PubMed  CAS  Google Scholar 

  292. Komaba H, Fukagawa M (2010) FGF23-parathyroid interaction: implications in chronic kidney disease. Kidney Int 77:292–298

    PubMed  CAS  Google Scholar 

  293. Komaba H, Goto S, Fujii H, et al. (2010a) Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 77:232–238

    PubMed  CAS  Google Scholar 

  294. Komaba H, Koizumi M, Fukagawa M (2010b) Parathyroid resistance to FGF23 in kidney transplant recipients: back to the past or ahead to the future? Kidney Int 78:953–955

    PubMed  CAS  Google Scholar 

  295. Levin A, Bakris GL, Molitch M, et al. (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31–38

    PubMed  CAS  Google Scholar 

  296. Li YC, Amling M, Pirro AE, et al. (1998) Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139:4391–4396

    PubMed  CAS  Google Scholar 

  297. Liu M, Lee MH, Cohen M, et al. (1996) Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142–153

    PubMed  CAS  Google Scholar 

  298. Lopez-Hilker S, Galceran T, Chan, YL, et al. (1986) Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure. J Clin Invest 78:1097–1102

    PubMed  CAS  Google Scholar 

  299. Mallya SM, Gallagher JJ, Wild YK, et al. (2005) Abnormal parathyroid cell proliferation precedes biochemical abnormalities in a mouse model of primary hyperparathyroidism. Mol Endocrinol 19:2603–2609

    PubMed  CAS  Google Scholar 

  300. Martinez I, Saracho R, Montenegro J, et al. (1997) The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 29:496–502

    PubMed  CAS  Google Scholar 

  301. Mendoza FJ, Lopez I, Canalejo R, et al. (2009) Direct upregulation of parathyroid calcium-sensing receptor and vitamin D receptor by calcimimetics in uremic rats. Am J Physiol Renal Physiol 296:F605–F613

    PubMed  CAS  Google Scholar 

  302. Moallem E, Kilav R, Silver J, et al. (1998) RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J Biol Chem 273:5253–5259

    PubMed  CAS  Google Scholar 

  303. Naveh-Many, T, Rahamimov, R, Livni, N, et al. (1995) Parathyroid cell proliferation in normal and chronic renal failure rats The effects of calcium, phosphate, and vitami.n D J Clin Invest 96:1786–1793

    PubMed  CAS  Google Scholar 

  304. Okazaki T, Zajac JD, Igarashi T, et al. (1991) Negative regulatory elements in the human parathyroid hormone gene. J Biol Chem 266:21903–21910

    PubMed  CAS  Google Scholar 

  305. Parfitt A (1997) The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int 52:3–9

    PubMed  CAS  Google Scholar 

  306. Patel SR, Ke HQ, Vanholder R, et al. (1995) Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest 96:50–59

    PubMed  CAS  Google Scholar 

  307. Portale AA, Halloran BP, Morris RC, Jr (1989) Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest 83:1494–1499

    PubMed  CAS  Google Scholar 

  308. Portale AA, Halloran BP, Morris RC, Jr, et al. (1996) Effect of aging on the metabolism of phosphorus and 1,25-dihydroxyvitamin D in healthy men. Am J Physiol, 270:E483–E490

    PubMed  CAS  Google Scholar 

  309. Ramirez JA, Goodman WG, Gornbein J, et al. (1993) Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism. J Clin Endocrinol Metab 76:1489–1494

    PubMed  CAS  Google Scholar 

  310. Sato T, Kikkawa Y, Hiramitsu T, et al. (2011) Role of multifunctional cell cycle modulators in advanced secondary hyperparathyroidism. Ther Apher Dial 15 Suppl 1:26–32

    PubMed  Google Scholar 

  311. Scherberich JE (2008) Kalzium-Phosphat- und Knochenstoffwechsel Surrogatparameter und ihr Bezug bei chronischer Niereninsuffizienz. Der Nephrologe 507–517

    Google Scholar 

  312. Seiler S, Heine GH, Fliser D (2009) Clinical relevance of FGF-23 in chronic kidney disease Kidney. Int Suppl S34–S42

    Google Scholar 

  313. Sela-Brown A, Russell J, Koszewski NJ, et al. (1998) Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats. Mol Endocrinol 12:1193–1200

    PubMed  CAS  Google Scholar 

  314. Shiizaki K, Hatamura I, Imazeki I, et al. (2009) Improvement of impaired calcium and skeletal homeostasis in vitamin D receptor knockout mice by a high dose of calcitriol and maxacalcitol. Bone 45:964–971

    PubMed  CAS  Google Scholar 

  315. Szabo A, Merke J, Beier E, et al. (1989) 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia Kidney Int 35:1049–1056

    PubMed  CAS  Google Scholar 

  316. Takahashi F, Denda M, Finch JL, et al. (2002) Hyperplasia of the parathyroid gland without secondary hyperparathyroidism. Kidney Int 61:1332–1338

    PubMed  Google Scholar 

  317. Tenenhouse HS, Murer H (2003) Disorders of renal tubular phosphate transport. J Am Soc Nephrol 14:240–248

    PubMed  Google Scholar 

  318. Alon DB, Chaimovitz C, Dvilansky A, et al. (2002) Novel role of 1,25(OH)(2)D(3) in induction of erythroid progenitor cell proliferation. Exp Hematol 30:403–409

    PubMed  Google Scholar 

  319. Ayus JC, Go AS, Valderrabano F, et al. (2005) Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL. Kidney Int 68:788–795

    PubMed  CAS  Google Scholar 

  320. Bardin T (2003) Musculoskeletal manifestations of chronic renal failure. Curr Opin Rheumatol 15:48–54

    PubMed  Google Scholar 

  321. Barletta G, De Feo ML, Del BR, et al. (2000) Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J Clin Endocrinol Metab 85:1815–1821

    PubMed  CAS  Google Scholar 

  322. Battistella M, Richardson RM, Bargman JM, et al. (2011) Improved parathyroid hormone control by cinacalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal disease. Clin Nephrol 76:99–103

    PubMed  CAS  Google Scholar 

  323. Baums MH, Klinger HM, Otte S (2003) Morbus Teutschlander – a massive soft-tissue calcification of the foot in a patient on long-term hemodialysis. Arch Orthop Trauma Surg 123:51–53

    PubMed  Google Scholar 

  324. Block GA, Hulbert-Shearon TE, Levin NW, et al. (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607–617

    PubMed  CAS  Google Scholar 

  325. Block GA, Klassen PS, Lazarus JM, et al. (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218

    PubMed  CAS  Google Scholar 

  326. Canaud B, Bragg-Gresham, JL, Marshall, MR, et al. (2006) Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS Kidney. Int 69:2087–2093

    CAS  Google Scholar 

  327. Chou FF, Ho JC, Huang SC, et al. (2000) A study on pruritus after parathyroidectomy for secondary hyperparathyroidism. J Am Coll Surg 190:65–70

    PubMed  CAS  Google Scholar 

  328. Chou FF, Lee CH, Chen JB, et al. (2005) Sleep disturbances before and after parathyroidectomy for secondary hyperparathyroidism. Surgery 137:426–430

    PubMed  Google Scholar 

  329. Cottone S, Nardi E, Mule G, et al. (2007) Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease. Clin Nephrol 67:209–216

    PubMed  CAS  Google Scholar 

  330. de Francisco AL (2004) Secondary hyperparathyroidism: review of the disease and its treatment. Clin Ther 26:1976–1993

    PubMed  Google Scholar 

  331. Denman ST (1986) A review of pruritus. J Am Acad Dermatol, 14:375–392

    PubMed  CAS  Google Scholar 

  332. Deutsche Gesellschaft für Nephrologie (2011) Daten und Fakten zur Niere und zu Nierenersatzverfahren

    Google Scholar 

  333. Dimkovic, N, Djukanovic, L, Radmilovic, A, et al. (1992) Uremic pruritus and skin mast cells. Nephron 61:5–9

    PubMed  CAS  Google Scholar 

  334. Drueke TB (1996) A clinical approach to the uraemic patient with extraskeletal calcifications. Nephrol Dial Transplant 11 Suppl 3:37–42

    PubMed  CAS  Google Scholar 

  335. Drueke TB, Eckard, K (2002) Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients. Nephrol Dial Transplant 17 Suppl 5:28–31

    PubMed  CAS  Google Scholar 

  336. Durrant-Finn U, Osten B, Mugge C, et al. (2009) [Pruritus and dryness of the skin in chronic kidney insufficiency and dialysis patients – a review]. Wien Med Wochenschr 159:317–326

    PubMed  Google Scholar 

  337. Esposito MG, Cesare CM, De Santo RM, et al. (2008) Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism. J Nephrol 21 Suppl 13:S92–S96

    PubMed  CAS  Google Scholar 

  338. Fineman I, Johnson JP, Di-Patre PL, et al. (1999) Chronic renal failure causing brown tumors and myelopathy Case report and review of pathophysiology and treatment. J Neurosurg 90:242–246

    PubMed  CAS  Google Scholar 

  339. Fliser D, Franek E, Fode P, et al. (1997) Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans Nephrol Dial Transplant 12:933–938

    PubMed  CAS  Google Scholar 

  340. Foley RN, Parfrey PS (1997) Cardiac disease in chronic uremia: clinical outcome and risk factors Adv Ren Replace Ther 4:234–248

    PubMed  CAS  Google Scholar 

  341. Foley RN, Parfrey PS, Harnett JD, et al. (1995) Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Kidney Int 47:186–192

    PubMed  CAS  Google Scholar 

  342. Fukagawa M, Komab, H, Onishi Y, et al. (2011) Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D Am J Nephrol 33:427–437

    PubMed  CAS  Google Scholar 

  343. Fusaro M, D'Angelo A, Naso A, et al. (2011) Treatment with calcimimetic (cinacalcet) alters epoetin dosage requirements in dialysis patients: preliminary report Ren Fail 33:732–735

    PubMed  CAS  Google Scholar 

  344. Gavelli G, Zompatori M (1997) Thoracic complications in uremic patients and in patients undergoing dialytic treatment: state of the art Eur Radiol 7:708–717

    PubMed  CAS  Google Scholar 

  345. Hampers CL, Katz AI, Wilson RE, et al. (1968) Disappearance of „uremic“ itching after subtotal parathyroidectomy. N Engl J Med 279:695–697

    PubMed  CAS  Google Scholar 

  346. Hara, S, Ubara Y, Arizono K, et al. (1995) Relation between parathyroid hormone and cardiac function in long-term hemodialysis patients. Miner Electrolyte Metab 21:72–76

    PubMed  CAS  Google Scholar 

  347. Held PJ, Brunner F, Odaka M, et al. (1990) Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 15:451–457

    PubMed  CAS  Google Scholar 

  348. Henschel A, Dannenberg L, Gobel U, et al. (1999) [Disseminated ischemic necrosis and livedo racemosa in a chronic dialysis patient with calciphylaxis]. Hautarzt 50:439–444

    PubMed  CAS  Google Scholar 

  349. Hiroshige K, Kabashima N, Takasugi M, et al. (1995) Optimal dialysis improves uremic pruritus. Am J Kidney Dis 25:413–419

    PubMed  CAS  Google Scholar 

  350. Hoeft D, Hillen U, Goos M, et al. (2004) [Painful ulcerating livid erythema in a 58-year old patient]. Hautarzt 55:562-566

    PubMed  CAS  Google Scholar 

  351. Horl WH, Haag-Weber M, Mai B, et al. (1995) Verapamil reverses abnormal [Ca2+]i and carbohydrate metabolism of PMNL of dialysis patients. Kidney Int 47:1741–1745

    PubMed  CAS  Google Scholar 

  352. Jevtic V (2003) Imaging of renal osteodystrophy. Eur J Radiol 46:85–95

    PubMed  CAS  Google Scholar 

  353. Kakuta T, Tanaka, R, Kanai, G, et al. (2009) Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism? Ther Apher Dial 13 Suppl 1:S20–S27

    PubMed  CAS  Google Scholar 

  354. Kleeman CR, Massry SG, Popovtzer MM, et al. (1968) The disappearance of intractable pruritus after parathyroidectomy in uremic patients with secondary hyperparathyroidism. Trans Assoc Am Physicians 81:203–212

    PubMed  CAS  Google Scholar 

  355. Lameire N, Jager K, Van BW, et al. (2005) Chronic kidney disease: a European perspective. Kidney Int Suppl:S30–S38

    Google Scholar 

  356. Leal CT, Lacativ, PG, Gomes, EM, et al. (2006) Surgical approach and clinical outcome of a deforming brown tumor at the maxilla in a patient with secondary hyperparathyroidism due to chronic renal failure. Arq Bras Endocrinol Metabol 50:963–967

    PubMed  Google Scholar 

  357. Li S, Chen YW, Peng Y, et al. (2011) Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007. Am J Kidney Di, 57:602–611

    Google Scholar 

  358. Limrick C, Nichols-Thomas C (2009) Anaemia and mineral bone disorder in chronic kidney disease: a review of the current literature and implications for clinical nursing practice. J Ren Care 35 Suppl 1:94–100

    PubMed  Google Scholar 

  359. Malberti F, Marcelli D, Conte F, et al. (2001) Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 12:1242–1248

    PubMed  CAS  Google Scholar 

  360. Massry SG, Popovtzer MM, Coburn JW, et al. (1968) Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia Disappearance of itching after subtotal parathyroidectomy. N Engl J Med 279:697–700

    PubMed  CAS  Google Scholar 

  361. Moe SM, Druek T (2008) Improving global outcomes in mineral and bone disorders. Clin J Am Soc Nephrol 3 Suppl 3:S127–S130

    PubMed  Google Scholar 

  362. Nappi S, Saha H, Virtanen V, et al. (2000) Left ventricular structure and function in primary hyperparathyroidism before and after parathyroidectomy. Cardiology 93:229–233

    PubMed  CAS  Google Scholar 

  363. Narita I, Iguchi S, Omori K, et al. (2008) Uremic pruritus in chronic hemodialysis patients. J Nephrol 21:161–165

    PubMed  Google Scholar 

  364. Parfrey PS, Harnett JD, Barre PE (1991) The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol 2:2–12

    PubMed  CAS  Google Scholar 

  365. Par CW, Oh YS, Shin YS, et al. (1999) Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 33:73–81

    Google Scholar 

  366. Pilz S, Tomaschitz, A, Drechsler, C, et al. (2010) Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 31:1591–1598

    PubMed  CAS  Google Scholar 

  367. Piovesan A, Molineri N, Casasso F, et al. (1999) Left ventricular hypertrophy in primary hyperparathyroidism Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 50:321–328

    CAS  Google Scholar 

  368. Ponticell C, Bencini PL (1992) Uremic pruritus: a review. Nephron 60:1–5

    Google Scholar 

  369. Raggi P, Chertow GM, Torres PU, et al. (2011) The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low–dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 26:1327–1339

    PubMed  CAS  Google Scholar 

  370. Rayner HC, Pisoni RL, Bommer J, et al. (2004) Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 19:108–120

    PubMed  Google Scholar 

  371. Scharer K, Schmidt KG, Soergel M (1999) Cardiac function and structure in patients with chronic renal failure. Pediatr Nephrol 13:951–965

    PubMed  CAS  Google Scholar 

  372. Schluter KD, Piper HM (1998) Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 37:34–41

    PubMed  CAS  Google Scholar 

  373. Schwarz G, Laukhuf F, Bittinger F, et al. (2000) [Calciphylaxis: ischemic tissue necrosis in chronic renal failure Case report and review of the literature]. Hautarzt 51:36–40

    PubMed  CAS  Google Scholar 

  374. Sedighi O, Makhlough A, Kashi Z, et al. (2011) Relationship between serum parathyroid hormone and hypertension in hemodialysis patients. Iran J Kidney Dis 5:267–270

    PubMed  Google Scholar 

  375. Shiota E, Tsuchiya K, Yamaoka K, et al. (2002) Spontaneous major tendon ruptures in patients receiving long-term hemodialysis. Clin Orthop Relat Res:236–242

    PubMed  Google Scholar 

  376. Slinin Y, Foley RN, Collins AJ (2007) Clinical epidemiology of parathyroidectomy in hemodialysis patients: the USRDS waves 1, 3, and 4 study. Hemodial Int 11:62–71

    PubMed  Google Scholar 

  377. Srivaths PR, Goldstei, SL, Silverstein DM, et al. (2011) Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol 26:945–951

    PubMed  Google Scholar 

  378. Stahle-Backdahl M, Hagermark O, Lins LE, et al. (1989) Experimental and immunohistochemical studies on the possible role of parathyroid hormone in uraemic pruritus. J Intern Med 225:411–415

    PubMed  CAS  Google Scholar 

  379. Stefenelli T, Abela C Frank H, et al. (1997) Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up J Clin Endocrinol Metab 82:106–112

    PubMed  CAS  Google Scholar 

  380. Stevens LA, Djurdje, O, Cardew S, et al. (2004) Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephro, 15:770–779

    CAS  Google Scholar 

  381. Strozecki P, Adamowicz A, Nartowic, E, et al. (2001) Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients. Ren Fail 23:115–126

    PubMed  CAS  Google Scholar 

  382. Taddei S, Nami R, Brun, RM, et al. (2011) Hypertension, left ventricular hypertrophy and chronic kidney disease. Heart Fail Rev 16:615–620

    PubMed  Google Scholar 

  383. Tentori F, Blayney MJ, Albert, JM, et al. (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52:519–530

    PubMed  CAS  Google Scholar 

  384. Trunzo JA, McHenry CR, Schulak JA, et al. (2008) Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism. Surgery 144:915–918

    PubMed  Google Scholar 

  385. Verma A Anavekar NS, Meris A, et al. (2007) The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study. J Am Coll Cardiol 50:1238–1245

    PubMed  Google Scholar 

  386. Voigtländer V (2005) Haut und Niere. In: Plewig P (Hrsg) Fortschritte der praktischen Dermatologie und Venerologie 2004. Springer, Berlin Heidelberg New York, pp 147–149.

    Google Scholar 

  387. West SL, Lok CE, Jamal SA (2010) Fracture Risk Assessment in Chronic Kidney Disease, Prospective Testing Under Real World Environments (FRACTURE): a prospective study. BMC Nephrol 11:17

    PubMed  Google Scholar 

  388. Whyte MP (1999) Extraskeletal (ectopic) calcification and ossification In Primer on the metabolic bone diseases and disorders of mineral metabolism (ed Whyte MP). Lippincott Williams & Wilkins, Philadelphia, pp 427–429

    Google Scholar 

  389. Wittenberg, A (2004) The rugger jersey spine sign. Radiolog, 230:491–492

    Google Scholar 

  390. Young EW, Akiba T, Albert JM, et al. (2004) Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Di, 44:34–38

    Google Scholar 

  391. Young EW, Albert JM, Satayathum S, et al. (2005) Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 67:1179–1187

    PubMed  CAS  Google Scholar 

  392. Zapolski T, Wysokinski A, Janicka L, et al. (2008) Aortic stiffness and valvular calcifications in patients with end-stage renal disease. Pol Arch Med Wewn 118:111–118

    PubMed  Google Scholar 

  393. Zoccali C, Mallamaci F, Tripepi G (2004) Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol, 15 Suppl 1:S77–S80

    PubMed  Google Scholar 

  394. Ernst M, Heath JK, Rodan GA (1989) Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825–833

    PubMed  CAS  Google Scholar 

  395. Felsenfeld AJ, Rodriguez M, Coleman M, et al. (1989) Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease. Kidney Int 35:1371–1378

    PubMed  CAS  Google Scholar 

  396. Hirai T, Nakashima A, Takasugi N, et al. (2010) Response of secondary hyperparathyroidism to cinacalcet depends on parathyroid size. Nephron Clin Pract 114:c187–c193

    PubMed  Google Scholar 

  397. Matsuoka S, Tominaga Y, Sato T, et al. (2008) Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism. Ther Apher Dial 12:391–395

    PubMed  Google Scholar 

  398. Mehl B, Delling G, Schlindwein I, et al. (2002) [Do markers of bone metabolism reflect the presence of a high- or low-turnover state of bone metabolism?]. Med Klin (Munich) 97:588–594

    CAS  Google Scholar 

  399. Meola M, Petrucci I, Calliada F, et al. (2011a) Presurgical setting of secondary hyperparathyroidism using high-resolution sonography and color Doppler. Ultraschall Med 32 Suppl 1:S74–S82

    PubMed  Google Scholar 

  400. Meola M, Petrucci I, Colombini E, et al. (2011b) Use of ultrasound to assess the response to therapy for secondary hyperparathyroidism. Am J Kidney Dis 58:485–491

    PubMed  Google Scholar 

  401. Okada M, Tominaga Y, Izumi K, et al. (2011) Tertiary hyperparathyroidism resistant to cinacalcet treatment. Ther Apher Dial 15 Suppl 1:33–37

    PubMed  Google Scholar 

  402. Ozcan UA, Okta, I (2009) Assessment of parathyroid glands in hemodialysis patients by using color Doppler sonography. Eur Radiol 19:2750–2755

    PubMed  Google Scholar 

  403. Tominaga Y, Matsuoka S, Sato T (2005) Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial 9:44–47

    PubMed  Google Scholar 

  404. Turner RT, Riggs BL, Spelsberg TC (1994) Skeletal effects of estrogen. Endocr Rev 15:275–300

    PubMed  CAS  Google Scholar 

  405. Vulpio C, Bossola M, De GA, et al. (2010) Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative evaluation of uremic secondary hyperparathyroidism. Head Neck 32:1226-1235

    PubMed  Google Scholar 

  406. Bergman A, Fenton SS, Richardson RM, et al. (2008) Reduction in cardiovascular related hospitalization with nocturnal home hemodialysis. Clin Nephrol 69:33–39

    PubMed  CAS  Google Scholar 

  407. Biggar PH, Liangos O, Fey H, et al. (2011) Vitamin D, chronic kidney disease and survival: a pluripotent hormone or just another bone drug? Pediatr Nephrol 26:7–18

    PubMed  Google Scholar 

  408. Block GA, Martin KJ, de Francisco AL, et al. (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516–1525

    PubMed  CAS  Google Scholar 

  409. Borchhardt KA, Diarra D, Sulzbacher I, et al. (2010) Cinacalcet decreases bone formation rate in hypercalcemic hyperparathyroidism after kidney transplantation. Am J Nephrol 31:482–489

    PubMed  Google Scholar 

  410. Borchhardt KA, Heinzl H, Mayerwoger E, et al. (2008) Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation Transplantation 86:919–924

    PubMed  CAS  Google Scholar 

  411. Bover J, Ortiz-Herbener F, Ballarin J, et al. (2005) [New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments]. Nefrologia 25 Suppl 2:100–108

    PubMed  Google Scholar 

  412. Burton DW, Foster M, Johnson KA, et al. (2005) Chondrocyte calcium-sensing receptor expression is up-regulated in early guinea pig knee osteoarthritis and modulates PTHrP, MMP-13, and TIMP-3 expression. Osteoarthritis Cartilage 13:395–404

    PubMed  CAS  Google Scholar 

  413. Cheng, S C, Young, D O, Huang, Y, et al. (2008) A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients. Clin J Am Soc Nephrol 3:1131–1138

    PubMed  CAS  Google Scholar 

  414. Copley JB, Wuthrich RP (2011) Therapeutic management of post-kidney transplant hyperparathyroidism. Clin Transplant 25:24–39

    PubMed  CAS  Google Scholar 

  415. Cunningham J, Danese M, Olson K, et al. (2005) Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 68:1793–1800

    PubMed  CAS  Google Scholar 

  416. Date T, Shigematsu T, Kawashita Y, et al. (2003) Colestimide can be used as a phosphate binder to treat uraemia in end-stage renal disease patients. Nephrol Dial Transplant 18 Suppl 3:iii90–iii93

    PubMed  CAS  Google Scholar 

  417. David DS (1977) Mineral and Bone Homeostasis in Renal Failure: Pathophysiology and Management. In: Davis DS (eds) Calcium Metabolism in Renal Failure and Nephrolithiasis. John Wiley & Sons, New York, pp 1–76

    Google Scholar 

  418. Drechsler C, Pilz S, Obermayer-Pietsch B, et al. (2010) Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J 3: 2253–2261

    Google Scholar 

  419. Fagugli RM, Reboldi G, Quintaliani G, et al. (2001) Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 38:371–376

    PubMed  CAS  Google Scholar 

  420. Falck P, Vethe NT, Asberg A, et al. (2008) Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients. Nephrol Dial Transplant 23:1048–1053

    PubMed  CAS  Google Scholar 

  421. Floege J, Kim J, Ireland E, et al. (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 26:1948–1955

    PubMed  CAS  Google Scholar 

  422. Ghazali A, Fardellone P, Pruna A, et al. (1999) Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int 55, 2169–2177

    PubMed  CAS  Google Scholar 

  423. Goodman WG (2002) Calcimimetic agents and secondary hyperparathyroidism: treatment and prevention Nephrol Dial Transplant, 17:204–207

    PubMed  CAS  Google Scholar 

  424. Heaf JG, Joffe P, Marckmann P (2011) Vitamin D and Stage 5 Chronic Kidney Disease: A New Paradigm? Semin Dial

    Google Scholar 

  425. Hemmelgarn BR, Manns BJ, Lloyd A, et al. (2010) Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303:423–429

    PubMed  CAS  Google Scholar 

  426. Hendy GN, Hruska KA, Mathew S, et al. (2006) New insights into mineral and skeletal regulation by active forms of vitamin D. Kidney Int 6:218–223

    Google Scholar 

  427. Henschkowski J, Bischoff-Ferrari HA, Wuthrich RP, et al. (2011) Renal function in patients treated with cinacalcet for persistent hyperparathyroidism after kidney transplantation. Kidney Blood Press Res 34:97–103

    PubMed  CAS  Google Scholar 

  428. Hofman-Bang J, Martuseviciene G, Santini MA, et al. (2010) Increased parathyroid expression of klotho in uremic rats. Kidney Int 78:1119–1127

    PubMed  CAS  Google Scholar 

  429. Isakova T, Gutierrez OM, Chang Y, et al. (2009) Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20:388–396

    PubMed  CAS  Google Scholar 

  430. Itoh K, Tanaka M, Hashiguchi J, et al. (2008) Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis. Ther Apher Dial 12:126–132

    PubMed  CAS  Google Scholar 

  431. Jean G, Souberbielle JC, Chazot C (2009) Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant 24:3799–3805

    PubMed  CAS  Google Scholar 

  432. Jean, G, Vanel, T, Terrat, J C, et al. (2010) Prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin D supplementation. Hemodial Int 14, 486–491

    PubMed  CAS  Google Scholar 

  433. Kalantar-Zadeh K, Shah A, Duong U, et al. (2010) Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl: S10–S21

    Google Scholar 

  434. Kandula P, Dobre M, Schold JD, et al. (2011) Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 6:50–62

    PubMed  CAS  Google Scholar 

  435. Kestenbaum B, Belozeroff V (2007) Mineral metabolism disturbances in patients with chronic kidney disease. Eur J Clin Invest 37:607–622

    PubMed  CAS  Google Scholar 

  436. Kim HS, Chung W, Kim S (2011) Vitamin d, and kidney disease Electrolyte. Blood Press 9:1–6

    CAS  Google Scholar 

  437. Kjellstrand C, Buoncristiani U, Ting G, et al. (2010) Survival with short-daily hemodialysis: association of time, site, and dose of dialysis. Hemodial Int 14:464–470

    PubMed  Google Scholar 

  438. Kjellstrand CM, Ing TS, Kjellstrand PT, et al. (2011) Phosphorus dynamics during hemodialysis. Hemodial Int 15:226–233

    PubMed  Google Scholar 

  439. Komaba H, Tanaka M, Fukagawa M (2008) Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) Intern Med, 4: 989–994

    Google Scholar 

  440. Kooienga L (2007) Phosphorus balance with daily dialysis. Semin Dial 20:342–345

    PubMed  Google Scholar 

  441. Kraus MA (2011) What hemodialysis strategy affords the longest patient survival? Semin Dial 24:420–421

    PubMed  Google Scholar 

  442. Lemmila S, Saha H, Virtanen V, et al. (1998) Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis. Am J Nephrol 18:404–410

    PubMed  CAS  Google Scholar 

  443. Levey AS, Eckardt KU, Tsukamoto Y, et al. (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 67:2089–2100

    PubMed  Google Scholar 

  444. Levey AS, Stevens LA, Coresh J (2009) Conceptual model of CKD: applications and implications. Am J Kidney Dis 53:S4–16

    PubMed  Google Scholar 

  445. Lewin E, Olgaard K (2009) When is Vitamin D contraindicated in dialysis patients? Semin Dia 22:240–242

    Google Scholar 

  446. Li YC, Amling M, Pirro AE, et al. (1998) Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139:4391–4396

    PubMed  CAS  Google Scholar 

  447. Li YC, Qiao G, Uskokovic M, et al. (2004) Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89–90:387–392

    PubMed  Google Scholar 

  448. Locatelli F (2004) The need for better control of secondary hyperparathyroidism. Nephrol Dial Transplant, 19 Suppl 5:V15–V19

    PubMed  Google Scholar 

  449. Lomonte C, Antonelli M, Vernaglione L, et al. (2005) Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients? J Nephrol 18:96–101

    PubMed  CAS  Google Scholar 

  450. Maass E, Mueller GA, Heller T, et al. (2007) Decrease in serum tacrolimus level and rise in serum creatinine under late addition of cinacalcet in a renal transplant recipient with hyperparathyroidism: a case report. Transplant Proc 39:3468–3470

    PubMed  CAS  Google Scholar 

  451. Macisaac RJ, Tsalamandris C, Panagiotopoulos S, et al. (2004) Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 27:195–200

    PubMed  Google Scholar 

  452. Messa P, Alfieri C, Rastaldi MP (2011) Recent insights into vitamin D and its receptor. J Nephrol 24 Suppl 18:S30–S37

    PubMed  CAS  Google Scholar 

  453. Miller, G, Davis, J, Shatzen, E, et al. (2011) Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD Nephrol Dial Transplant

    Google Scholar 

  454. Moe SM, Chertow GM (2006) The case against calcium-based phosphate binders. Clin J Am Soc Nephrol 1:697–703

    PubMed  CAS  Google Scholar 

  455. Moe SM, Chertow, GM, Coburn JW, et al. (2005a) Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 67:760–771

    PubMed  CAS  Google Scholar 

  456. Moe SM, Cunningham J, Bommer J, et al. (2005b) Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrol Dial Transplant 20:2186–2193

    PubMed  CAS  Google Scholar 

  457. Moe SM, Drueke TB (2011) The KDIGO guideline on dialysate calcium and patient outcomes: need for hard evidence. Kidney Int 79:478–479

    PubMed  Google Scholar 

  458. Muller D, Mehling H, Otto B, et al. (2007) Niacin lowers serum phosphate and increases HDL cholesterol in dialysis patients. Clin J. Am Soc Nephrol 2:1249–1254

    PubMed  Google Scholar 

  459. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2011) DIVINE: Dialysis Infection and Vitamin D In New England

    Google Scholar 

  460. NKF (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–266

    Google Scholar 

  461. NN (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–201

    Google Scholar 

  462. Ok E, Asci G, Duman S, et al. (2008) Reduction of Calcium Exposure Slows down Progression of Vascular Calcification and Improves. Adynamic Bone Disease

    Google Scholar 

  463. Okada M, Tominaga Y, Izumi K, et al. (2011) Tertiary hyperparathyroidism resistant to cinacalcet treatment Ther Apher Dial 15 Suppl 1:33–37

    PubMed  Google Scholar 

  464. Park CW, Oh YS, Shin YS, et al. (1999) Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 33:73–81

    PubMed  CAS  Google Scholar 

  465. Reichel H, Koeffle HP, Norman AW (1989) The role of the vitamin D endocrine system in health and disease. N Engl J Med 320:980–991

    PubMed  CAS  Google Scholar 

  466. Restrepo Valencia, CA, Cruz, J (2008) [Safety and effectiveness of nicotinic acid in the management of patients with chronic renal disease and hyperlipidemia associated to hyperphosphatemia]. Nefrologia 28:61–66

    PubMed  CAS  Google Scholar 

  467. Sampathkumar K, Selvam M, Sooraj YS, et al. (2006) Extended release nicotinic acid – a novel oral agent for phosphate control. Int Urol Nephrol, 38:171–174

    PubMed  CAS  Google Scholar 

  468. Saran R, Bragg-Gresham JL, Levin NW, et al. (2006) Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 69:1222–1228

    PubMed  CAS  Google Scholar 

  469. Schomig M, Ritz E (2000) Management of disturbed calcium metabolism in uraemic patients: 3 Potential perspectives – calcimimetics. Nephrol Dial Transplant 15 Suppl 5:30–31

    PubMed  Google Scholar 

  470. Schwarz A, Merkel S, Leitolf H, et al. (2011) The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism. Transplantation 91:560–565

    PubMed  Google Scholar 

  471. Seyffart G, Schulz T, Stiller S (2009) Use of two calcium concentrations in hemodialysis--report of a 20-year clinical experience. Clin Nephrol 71:296–305

    PubMed  CAS  Google Scholar 

  472. Spurney RF, Pi M, Flannery P, et al. (1999) Aluminum is a weak agonist for the calcium-sensing receptor. Kidney Int 55:1750–1758

    PubMed  CAS  Google Scholar 

  473. Stubbs JR, Wetmore JB (2011) Does it matter how parathyroid hormone levels are suppressed in secondary hyperparathyroidism? Semin Dial 24:298–306

    PubMed  Google Scholar 

  474. Sumida K, Nakamura M, Ubara Y, et al. (2011) Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride. J Clin Pathol 64:756–760

    PubMed  CAS  Google Scholar 

  475. Takahashi Y, Tanaka A, Nakamura T, et al. (2004) Nicotinamide suppresses hyperphosphatemia in hemodialysis patients. Kidney Int 65:1099–1104

    PubMed  CAS  Google Scholar 

  476. Tanaka M, Tokunaga K, Komaba H, et al. (2011) Vitamin D receptor activator reduces oxidative stress in hemodialysis patients with secondary hyperparathyroidism. Ther Apher Dial 15:161–168

    PubMed  CAS  Google Scholar 

  477. Teng M, Wolf M, Ofsthun MN, et al. (2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16:1115–1125

    PubMed  CAS  Google Scholar 

  478. Tentori F, Albert JM, Young EW, et al. (2009) The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 24:963–972

    PubMed  CAS  Google Scholar 

  479. Tentori F, Hunt WC, Stidley CA, et al. (2006) Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 70:1858–1865

    PubMed  CAS  Google Scholar 

  480. Thomas MC, Macisaac RJ, Jerums G, et al. (2009) Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care 32:1497–1502

    PubMed  Google Scholar 

  481. Tonelli M, Wang W, Hemmelgarn B, et al. (2009) Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients. Am J Kidney Dis 54:1108–1115

    PubMed  CAS  Google Scholar 

  482. Torres A, Lorenzo V, Hernandez D, et al. (1995) Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 47:1434–1442

    PubMed  CAS  Google Scholar 

  483. Troidle L, Hotchkiss M, Finkelstein F (2007) A thrice weekly in-center nocturnal hemodialysis program Adv Chronic Kidney Dis 14:244–248

    PubMed  Google Scholar 

  484. Wada M, Nagano N (2003) Control of parathyroid cell growth by calcimimetics. Nephrol Dial Transplant 18 Suppl 3:iii13–iii17

    PubMed  CAS  Google Scholar 

  485. Wada M, Nagano N, Nemeth EF (1999) The calcium receptor and calcimimetics. Curr Opin Nephrol Hypertens 8:429–433

    PubMed  CAS  Google Scholar 

  486. Weinreich T, De los,RT, Gauly A, et al. (2006) Effects of an increase in time vs frequency on cardiovascular parameters in chronic hemodialysis patients. Clin Nephrol 66:433–439

    PubMed  CAS  Google Scholar 

  487. Wolf M (2011) Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone? Semin Dial 24:428–430

    PubMed  Google Scholar 

  488. Yamada K, Fujimoto S, Nishiura R, et al. (2007) Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis. Nephrol Dial Transplant 22:2032–2037

    PubMed  Google Scholar 

  489. Yamamoto M, Ogata H, Mizobuchi M, et al. (2011) Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism. Clin Exp Nephrol

    Google Scholar 

  490. Zitt E, Woess E, Mayer G, et al. (2011) Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism. Transplantation 92:883–889

    PubMed  CAS  Google Scholar 

  491. Akerstrom G, Malmaeus J, Bergstrom R (1984) Surgical anatomy of human parathyroid glands. Surgery 95 (1):14–21

    PubMed  CAS  Google Scholar 

  492. Akerstrom G, Rastad J, Ljunghall S, Ridefelt P, Juhlin C, Gylfe E (1991) Cellular physiology and pathophysiology of the parathyroid glands. World J Surg 15 (6):672–680

    PubMed  CAS  Google Scholar 

  493. Akerstrom G, Rudberg C, Grimelius L, Rastad J (1988) Recurrent hyperparathyroidism due to peroperative seeding of neoplastic or hyperplastic parathyroid tissue. Case report. Acta Chir Scand 154 (9):549–552

    PubMed  CAS  Google Scholar 

  494. Aly A, Douglas M (2003) Embryonic parathyroid rests occur commonly and have implications in the management of secondary hyperparathyroidism. ANZ J Surg 73 (5):284–288

    PubMed  Google Scholar 

  495. Aston JP, Wheeler MH, Brown RC, Curley IR, Woodhead JS (1988) Studies on in vivo and in vitro release of intact parathyroid hormone using a new two-site immunochemiluminometric assay. World J Surg 12 (4):454–462

    PubMed  CAS  Google Scholar 

  496. Barbaros U, Erbil Y, Yildirim A, Saricam G, Yazici H, Ozarmağan S (2009) Minimally invasive video-assisted subtotal parathyroidectomy with thymectomy for secondary hyperparathyroidism. Langenbecks Arch Surg 394 (3):451–455

    PubMed  Google Scholar 

  497. Barczyński M, Cichoń S, Konturek A, Cichoń W (2005) A randomised study on a new cost-effective algorithm of quick intraoperative intact parathyroid hormone assay in secondary hyperparathyroidism. Langenbecks Arch Surg 390 (2):121–127

    PubMed  Google Scholar 

  498. Bieglmayer C, Kaczirek K, Prager G, Niederle B (2006) Parathyroid hormone monitoring during total parathyroidectomy for renal hyperparathyroidism: pilot study of the impact of renal function and assay specificity. Clin Chem 52 (6):1112–1119

    PubMed  CAS  Google Scholar 

  499. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350 (15):1516–1525

    Google Scholar 

  500. Blomme RA, Blomme AM, Rinkes IH, Meerwaldt R, van der Wal MB, Valk GD, Vriens MR (2010) Surgical strategy in patients with secondary and tertiary hyperparathyroidism. A bi-institutional series. Acta Chir Belg 110 (1):35–39

    PubMed  CAS  Google Scholar 

  501. Borot S, Lapierre V, Carnaille B, Goudet P, Penfornis A (2010) Results of cryopreserved parathyroid autografts: a retrospective multicenter study. Surgery 147 (4):529–535

    PubMed  Google Scholar 

  502. Brancaccio D, Cozzolino M (2011) CKD-MBD: an endless story. J Nephrol 24 Suppl 18:S42–48

    PubMed  Google Scholar 

  503. Brown AJ (2001) Therapeutic uses of vitamin D analogues. Am J Kidney Dis 38 (5 Suppl 5):S3–S19

    PubMed  CAS  Google Scholar 

  504. Burgstaller T, Riss P, Asari R, Scheuba C, Bieglmayer C, Kaczirek K, Niederle B (2012) Does technically defined „total parathyroidectomy” stand the biochemical test? – A short and long-term follow-up of patients with secondary hyperparathyroidism. sent for publication

    Google Scholar 

  505. Chan HW, Chu KH, Fung SK, Tang HL, Lee W, Cheuk A, Yim KF, Tong MK, Lee KC (2010) Prospective study on dialysis patients after total parathyroidectomy without autoimplant. Nephrology (Carlton) 15 (4):441–447

    Google Scholar 

  506. Chertow GM, Moe SM (2005) Calcification or classification? J Am Soc Nephrol 16 (2):293–295

    PubMed  Google Scholar 

  507. Chou FF, Chan HM, Huang TJ, Lee CH, Hsu KT (1998) Autotransplantation of parathyroid glands into subcutaneous forearm tissue for renal hyperparathyroidism. Surgery 124 (1):1–5

    PubMed  CAS  Google Scholar 

  508. Chou FF, Lee CH, Chen JB, Hsu KT, Sheen-Chen SM (2002) Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism. Arch Surg 137 (3):341–344

    PubMed  CAS  Google Scholar 

  509. Clary BM, Garner SC, Leight GS, Jr. (1997) Intraoperative parathyroid hormone monitoring during parathyroidectomy for secondary hyperparathyroidism. Surgery 122 (6):1034–1038; discussion 1038–1039

    PubMed  CAS  Google Scholar 

  510. Coburn JW, Salusky IB (1994) Hyperparathyroidism in Renal Failure. In: The Parathyroids. Reve Press, New Yok

    Google Scholar 

  511. Cohen EP, Moulder JE (2001) Parathyroidectomy in chronic renal failure: has medical care reduced the need for surgery? Nephron 89 (3):271–273

    PubMed  CAS  Google Scholar 

  512. Cohen MS, Dilley WG, Wells SA, Moley JF, Doherty GM, Sicard GA, Skinner MA, Norton JA, DeBenedetti MK, Lairmore TC (2005) Long-term functionality of cryopreserved parathyroid autografts: a 13-year prospective analysis. Surgery 138 (6):1033–1040; discussion 1040–1031

    PubMed  Google Scholar 

  513. Conzo G, Perna AF, Sinisi AA, Palazzo A, Stanzione F, Della Pietra C, Livrea A (2011) Total parathyroidectomy without autotransplantation in the surgical treatment of secondary hyperparathyroidism of chronic kidney disease. J Endocrinol Invest doi:7621 [pii] 10.3275/7621

    PubMed  Google Scholar 

  514. Coulston JE, Egan R, Willis E, Morgan JD (2010) Total parathyroidectomy without autotransplantation for renal hyperparathyroidism. Br J Surg 97 (11):1674–1679

    PubMed  CAS  Google Scholar 

  515. Craver L, Marco MP, Martinez I, Rue M, Borras M, Martin ML, Sarro F, Valdivielso JM, Fernandez E (2007) Mineral metabolism parameters throughout chronic kidney disease stages 1-5 – achievement of K/DOQI target ranges. Nephrol Dial Transplant 22 (4):1171–1176

    PubMed  CAS  Google Scholar 

  516. Cunningham J (2004) Achieving therapeutic targets in the treatment of secondary hyperparathyroidism. Nephrol Dial Transplant 19 Suppl 5:V9–14

    PubMed  CAS  Google Scholar 

  517. De Francisco AL, Fresnedo GF, Rodrigo E, Pinera C, Amado JA, Arias M (2002) Parathyroidectomy in dialysis patients. Kidney Int Suppl (80):161–166

    PubMed  Google Scholar 

  518. de la Rosa A, Jimeno J, Membrilla E, Sancho JJ, Pereira JA, Sitges-Serra A (2008) Usefulness of preoperative Tc-mibi parathyroid scintigraphy in secondary hyperparathyroidism. Langenbecks Arch Surg 393 (1):21–24

    PubMed  Google Scholar 

  519. DeAlessandro AM MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Vernon WB, Belzer FO, Starling JR (1989) Tertiary hyperparathyroidism after renal transplation: Operative indications. Surgery 106:1049

    Google Scholar 

  520. Debruyne F, Geuens G, Vander Poorten V, Delaere P (2008) Re–operation for secondary hyperparathyroidism. J Laryngol Otol 122 (9):942-947

    PubMed  CAS  Google Scholar 

  521. Donckier V, Decoster-Gervy C, Kinnaert P (1997) Long-term results after surgical treatment of renal hyperparathyroidism when fewer than four glands are identified at operation. J Am Coll Surg 184 (1):70–74

    PubMed  CAS  Google Scholar 

  522. Dotzenrath C (2010) [Indications for parathyroidectomy in renal hyperparathyroidism: comments on the significance of new therapeutics]. Chirurg 81 (10):902–908

    PubMed  CAS  Google Scholar 

  523. Drakopoulos S, Koukoulaki M, Apostolou T, Pistolas D, Balaska K, Gavriil S, Hadjiconstantinou V (2009) Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation. Am J Surg 198 (2):178–183

    PubMed  Google Scholar 

  524. Drueke TB (2000) Cell biology of parathyroid gland hyperplasia in chronic renal failure. J Am Soc Nephrol 11 (6):1141–1152

    PubMed  CAS  Google Scholar 

  525. Drüeke TB (1995) The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int 48 (1):259–272

    PubMed  Google Scholar 

  526. Drueke TB, Zingraff J (1994) The dilemma of parathyroidectomy in chronic renal failure. Curr Opin Nephrol Hypertens 3 (4):386–395

    PubMed  CAS  Google Scholar 

  527. Echenique-Elizondo M, Amondarain JA, Vidaur F, Olalla C, Aribe F, Garrido A, Molina J, Rodrigo MT (2007) Parathyroid subcutaneous pre-sternal transplantation after parathyroidectomy for renal hyperparathyroidism. Long-term graft function. World J Surg 31 (7):1403–1409

    PubMed  Google Scholar 

  528. Echenique-Elizondo M, Díaz-Aguirregoitia FJ, Amondarain JA, Vidaur F (2006) Parathyroid graft function after presternal subcutaneous autotransplantation for renal hyperparathyroidism. Arch Surg 141 (1):33–38

    PubMed  Google Scholar 

  529. Echenique Elizondo M, Diaz-Aguirregoitia FJ, Amondarain JA, Vidaur F (2005) Intraoperative monitoring of intact PTH in surgery for renal hyperparathyroidism as an indicator of complete parathyroid removal. World J Surg 29 (11):1504–1509

    PubMed  Google Scholar 

  530. Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y (2004) Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 19 (5):1281–1287

    Google Scholar 

  531. Evenepoel P, Claes K, Kuypers DR, Debruyne F, Vanrenterghem Y (2007) Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrol Dial Transplant 22 (6):1730–1737

    PubMed  Google Scholar 

  532. Farrington K, Varghese Z, Chan MK, Fernando ON, Baillod RA, Sweny P, Moorhead JF (1987) How complete is a total parathyroidectomy in uraemia? Br Med J (Clin Res Ed) 294 (6574):743

    CAS  Google Scholar 

  533. Fassbinder W, Brunner FP, Brynger H, Ehrich JH, Geerlings W, Raine AE, Rizzoni G, Selwood NH, Tufveson G, Wing AJ (1991) Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant 6 Suppl 1:5–35

    Google Scholar 

  534. Felsenfeld A (1997) Considerations for the Treatment of Secondary Hyperparathyroidsm in Renal Failure. J Am Soc Nephrol 7:993

    Google Scholar 

  535. Felts JH, Whitley JE, Anderson DD, Carpenter HM, Bradshaw HH (1965) Medical and Surgical Treatment of Azotemic Osteodystrophy. Ann Intern Med 62:1272–1279

    PubMed  CAS  Google Scholar 

  536. Foley RN, Li S, Liu J, Gilbertson DT, Chen SC, Collins AJ (2005) The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol 16 (1):210–218

    PubMed  Google Scholar 

  537. Fordham CC, 3rd, Williams TF (1963) Brown tumor and secondary hyperparathyroidism. N Engl J Med 269:129–131

    PubMed  Google Scholar 

  538. Freriks K, Hermus AR, de Sévaux RG, Bonenkamp HJ, Biert J, den Heijer M, Sweep FC, van Hamersvelt HW (2010) Usefulness of intraoperative parathyroid hormone measurements in patients with renal hyperparathyroidism. Head Neck 32 (10):1328–1335

    PubMed  Google Scholar 

  539. Gasparri G, Camandona M, Bertoldo U, Sargiotto A, Papotti M, Raggio E, Nati L, Martino P, Felletti G, Mengozzi G (2009) The usefulness of preoperative dual-phase 99mTc MIBI-scintigraphy and IO-PTH assay in the treatment of secondary and tertiary hyperparathyroidism. Ann Surg 250 (6):868–871

    PubMed  Google Scholar 

  540. Gioviale MC, Gambino G, Maione C, Luna E, Calderone F, Di Bona A, Buscemi G, Romano M, Lo Monte AI (2006) Intraoperative parathyroid hormone monitoring during parathyroidectomy for hyperparathyroidism in waiting list and kidney transplant patients. Transplant Proc 38 (4):1003–1005

    PubMed  CAS  Google Scholar 

  541. Gioviale MC, Gambino G, Maione C, Romano G, Damiano G, Cocchiara G, Pirrotta C, Moscato F, Lo Monte AI, Buscemi G, Romano M (2007) Use of monitoring intraoperative parathyroid hormone during parathyroidectomy in patients on waiting list for renal transplantation. Transplant Proc 39 (6):1775–1778

    PubMed  CAS  Google Scholar 

  542. Girotto JA, Harmon JW, Ratner LE, Nicol TL, Wong L, Chen H (2001) Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism. Surgery 130 (4):645–650; discussion 650–641

    PubMed  CAS  Google Scholar 

  543. Gomes EM, Nunes RC, Lacativa PG, Almeida MH, Franco FM, Leal CT, Patrício Filho PJ, Farias ML, Gonçalves MD (2007) Ectopic and extranumerary parathyroid glands location in patients with hyperparathyroidism secondary to end stage renal disease. Acta Cir Bras 22 (2):105–109

    PubMed  Google Scholar 

  544. Grant CS (2008) Long-term Results of Subtotal vs Total Parathyroidectomy Without Autotransplantation in Kidney Transplant Recipients – Invited Critique. Arch Surg 143 (8)

    Google Scholar 

  545. Group KDIGOC-MW (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (113):S1–130

    Google Scholar 

  546. Guerrero MA, Evans DB, Lee JE, Bao R, Bereket A, Gantela S, Griffin GD, Perrier ND (2008) Viability of cryopreserved parathyroid tissue: when is continued storage versus disposal indicated? World J Surg 32 (5):836–839

    PubMed  Google Scholar 

  547. Hampl H, Steinmuller T, Stabell U, Klingenberg HJ, Schnoy N, Neuhaus P (1991) Recurrent hyperparathyroidism after total parathyroidectomy and autotransplantation in patients with long-term hemodialysis. Miner Electrolyte Metab 17 (4):256–260

    PubMed  CAS  Google Scholar 

  548. Harrison BJ, Triponez F (2009) Intraoperative adjuncts in surgery for primary hyperparathyroidism. Langenbecks Arch Surg 394 (5):799–809

    PubMed  Google Scholar 

  549. Haustein SV, Mack E, Starling JR, Chen H (2005) The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation. Surgery 138 (6):1066–1071; discussion 1071

    PubMed  Google Scholar 

  550. Hibi Y, Tominaga Y, Uchida K, Takagi H, Imai T, Funahashi H, Nakao A (2002) Cases with fewer than four parathyroid glands in patients with renal hyperparathyroidism at initial parathyroidectomy. World J Surg 26 (3):314–317

    PubMed  Google Scholar 

  551. Hidai H, Chiba T, Takagi Y, Mori T, Taniguchi T, Hyodo T (1998) Percutaneous autotransplantation of parathyroid tissue into the forearm muscles. Surg Today 28 (1):114–116

    PubMed  CAS  Google Scholar 

  552. Higgins RM, Richardson AJ, Ratcliffe PJ, Woods CG, Oliver DO, Morris PJ (1991) Total parathyroidectomy alone or with autograft for renal hyperparathyroidism? Q J Med 79 (288):323–332

    PubMed  CAS  Google Scholar 

  553. Ikeda Y, Kurihara H, Morita N, Miyabe R, Takami H (2007a) The role of quick bio-intact PTH(1-84) assay during parathyroidectomy for secondary hyperparathyroidism. J Surg Res 141 (2):306–310

    PubMed  CAS  Google Scholar 

  554. Ikeda Y, Kurihara H, Morita N, Miyabe R, Takami H (2007b) Significance of monitoring Bio-Intact PTH (1-84) during parathyroidectomy for secondary hyperparathyroidism. J Surg Res 139 (1):83–87

    PubMed  CAS  Google Scholar 

  555. Ikeda Y, Takami H, Niimi M, Kan S, Sasaki Y, Takayama J (2002) Endoscopic total parathyroidectomy by the anterior chest approach for renal hyperparathyroidism. Surg Endosc 16 (2):320–322

    PubMed  CAS  Google Scholar 

  556. Jorna FH, Tobe TJ, Huisman RM, de Jong PE, Plukker JT, Stegeman CA (2004) Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy. Nephrol Dial Transplant 19 (5):1168–1173

    PubMed  Google Scholar 

  557. Kaczirek K, Prager G, Riss P, Wunderer G, Asari R, Scheuba C, Bieglmayer C, Niederle B (2006) Novel parathyroid hormone (1–84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism. Arch Surg 141 (2):129–134; discussion 134

    PubMed  CAS  Google Scholar 

  558. Kaczirek K, Riss P, Wunderer G, Prager G, Asari R, Scheuba C, Bieglmayer C, Niederle B (2005) Quick PTH assay cannot predict incomplete parathyroidectomy in patients with renal hyperparathyroidism. Surgery 137 (4):431–435

    PubMed  Google Scholar 

  559. Kakuta T, Tanaka R, Kanai G, Miyamoto Y, Inagaki M, Suzuki H, Fukagawa M, Saito A (2008) Relationship between the weight of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism. Ther Apher Dial 12 (5):385–390

    PubMed  Google Scholar 

  560. Kandil E, Florman S, Alabbas H, Abdullah O, McGee J, Noureldine S, Slakey D, Zhang R (2010) Exploring the effect of parathyroidectomy for tertiary hyperparathyroidism after kidney transplantation. Am J Med Sci 339 (5):420–424

    PubMed  Google Scholar 

  561. Kara M, Tellioglu G, Bugan U, Krand O, Berber I, Seymen P, Eren PA, Ozel L, Titiz I (2010) Evaluation of intraoperative parathormone measurement for predicting successful surgery in patients undergoing subtotal/total parathyroidectomy due to secondary hyperparathyroidism. Laryngoscope 120 (8):1538–1544

    PubMed  CAS  Google Scholar 

  562. Kaye M, D'Amour P, Henderson J (1989) Elective total parathyroidectomy without autotransplant in end-stage renal disease. Kidney Int 35 (6):1390–1399

    PubMed  CAS  Google Scholar 

  563. Kebebew E, Duh QY, Clark OH (2004) Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy. Arch Surg 139 (9):974–977

    PubMed  Google Scholar 

  564. Kerby JD, Rue LW, Blair H, Hudson S, Sellers MT, Diethelm AG (1998) Operative treatment of tertiary hyperparathyroidism: a single-center experience. Ann Surg 227 (6):878–886

    PubMed  CAS  Google Scholar 

  565. Kestenbaum B, Seliger SL, Gillen DL, Wasse H, Young B, Sherrard DJ, Weiss NS, Stehman-Breen CO (2004) Parathyroidectomy rates among United States dialysis patients: 1990-1999. Kidney Int 65 (1):282–288

    PubMed  Google Scholar 

  566. Kinnaert P, Salmon I, Decoster-Gervy C, Bergman P, Hooghe L, De Pauw L, Van Geertruyden J (1993) Total parathyroidectomy and presternal subcutaneous implantation of parathyroid tissue for renal hyperparathyroidism. Surg Gynecol Obstet 176 (2):135–138

    PubMed  CAS  Google Scholar 

  567. Kinnaert P, Salmon I, Decoster-Gervy C, Vienne A, De Pauw L, Hooghe L, Tielemans C (2000) Long-term results of subcutaneous parathyroid grafts in uremic patients. Arch Surg 135 (2):186–190

    PubMed  CAS  Google Scholar 

  568. Lando MJ, Hoover LA, Zuckerbraun L, Goodman D (1988) Autotransplantation of parathyroid tissue into sternocleidomastoid muscle. Arch Otolaryngol Head Neck Surg 114 (5):557–560

    PubMed  CAS  Google Scholar 

  569. Li S, Chen YW, Peng Y, Foley RN, St Peter WL (2011) Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007. Am J Kidney Dis 57 (4):602–611

    PubMed  Google Scholar 

  570. Liechty RD, Weil R, 3rd (1984) The anatomy of parathyroid hyperplasia. Surgery 96 (6):1099–1102

    PubMed  CAS  Google Scholar 

  571. Lieu D, Hirschowitz SL, Skinner KA, Zuckerbraun L (1998) Recurrent secondary hyperparathyroidism after autotransplantation into the sternocleidomastoid muscle: report of a case with fine needle aspiration findings. Acta Cytol 42 (5):1195–1198

    PubMed  CAS  Google Scholar 

  572. Ljutic D, Cameron JS, Ogg CS, Turner C, Hicks JA, Owen WJ (1994) Long-term follow-up after total parathyroidectomy without parathyroid reimplantation in chronic renal failure. QJM 87 (11):685–692

    PubMed  CAS  Google Scholar 

  573. Lokey J, Pattou F, Mondragon-Sanchez A, Minuto M, Mullineris B, Wambergue F, Foissac-Geroux P, Noel C, de Sagazan HL, VanHille P, Proye CA (2000) Intraoperative decay profile of intact (1-84) parathyroid hormone in surgery for renal hyperparathyroidism--a consecutive series of 80 patients. Surgery 128 (6):1029–1034

    PubMed  CAS  Google Scholar 

  574. Lomonte C, Buonvino N, Selvaggiolo M, Dassira M, Grasso G, Vernaglione L, Basile C (2006) Sestamibi scintigraphy, topography, and histopathology of parathyroid glands in secondary hyperparathyroidism. Am J Kidney Dis 48 (4):638–644

    PubMed  Google Scholar 

  575. Lorenz K, Dralle H (2005) Will intra-operative measurement of parathyroid hormone alter the surgical concept of renal hyperparathyroidism? Langenbecks Arch Surg 390 (4):277–279

    PubMed  CAS  Google Scholar 

  576. Lorenz K, Ukkat J, Sekulla C, Gimm O, Brauckhoff M, Dralle H (2006) Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol. World J Surg 30 (5):743–751

    PubMed  Google Scholar 

  577. Malberti F, Marcelli D, Conte F, Limido A, Spotti D, Locatelli F (2001) Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 12 (6):1242–1248

    PubMed  CAS  Google Scholar 

  578. Matsuoka S, Tominaga Y, Sato T, Uno N, Goto N, Katayama A, Uchida K, Takami H (2007a) QuiCk-IntraOperative Bio-Intact PTH assay at parathyroidectomy for secondary hyperparathyroidism. World J Surg 31 (4):824–831

    PubMed  Google Scholar 

  579. Matsuoka S, Tominaga Y, Sato T, Uno N, Goto N, Katayama A, Uchida K, Tsuzuki T (2007b) Recurrent renal hyperparathyroidism caused by parathyromatosis. World J Surg 31 (2):299–305

    PubMed  Google Scholar 

  580. Matsuoka S, Tominaga Y, Sato T, Uno N, Hiramitu T, Goto N, Nagasaka T, Uchida K (2008) Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism. Ther Apher Dial 12 (5):391–395

    PubMed  Google Scholar 

  581. Matsuoka S, Tominaga Y, Uno N, Goto N, Sato T, Katayama A, Haba T, Uchida K, Kobayashi K, Nakao A (2005) Calciphylaxis: a rare complication of patients who required parathyroidectomy for advanced renal hyperparathyroidism. World J Surg 29 (5):632–635

    PubMed  Google Scholar 

  582. Matsuoka S, Tominaga Y, Uno N, Goto N, Sato T, Katayama A, Uchida K, Nakao A (2006) Surgical significance of undescended parathyroid gland in renal hyperparathyroidism. Surgery 139 (6):815–820

    PubMed  Google Scholar 

  583. Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM, Barresi G, Pugliese F (2008) Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients. Nephrol Dial Transplant 23 (7):2319–2323

    PubMed  CAS  Google Scholar 

  584. McPhaul JJ, Jr., McIntosh DA, Hammond WS, Park OK (1964) Autonomous Secondary (Renal) Parathyroid Hyperplasia. N Engl J Med 271:1342–1345

    PubMed  Google Scholar 

  585. Meakins JL, Milne CA, Hollomby DJ, Goltzman D (1984) Total parathyroidectomy: parathyroid hormone levels and supernumerary glands in hemodialysis patients. Clin Invest Med 7 (1):21–25

    PubMed  CAS  Google Scholar 

  586. Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G, KDIGO (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69 (11):1945–1953

    PubMed  CAS  Google Scholar 

  587. Moffett JM, Suliburk J (2011) Parathyroid autotransplantation. Endocr Pract 17 Suppl 1:83–89

    PubMed  Google Scholar 

  588. Monchik JM, Bendinelli C, Passero MA, Roggin KK (1999) Subcutaneous forearm transplantation of autologous parathyroid tissue in patients with renal hyperparathyroidism. Surgery 126 (6):1152–1158; discussion 1158–1159

    PubMed  CAS  Google Scholar 

  589. Moor JW, Roberts S, Atkin SL, England RJ (2011) Intraoperative parathyroid hormone monitoring to determine long-term success of total parathyroidectomy for secondary hyperparathyroidism. Head Neck 33 (3):293–296

    PubMed  Google Scholar 

  590. Mourad M, Ngongang C, Saab N, Coche E, Jamar F, Michel JM, Maiter D, Malaise J, Squifflet JP (2001) Video-assisted neck exploration for primary and secondary hyperparathyroidism: initial experience. Surg Endosc 15 (10):1112–1115

    PubMed  CAS  Google Scholar 

  591. Müller-Stich BP, Brändle M, Binet I, Warschkow R, Lange J, Clerici T (2007) To autotransplant simultaneously or not – can intraoperative parathyroid hormone monitoring reliably predict early postoperative parathyroid hormone levels after total parathyroidectomy for hyperplasia? Surgery 142 (1):47–56

    PubMed  Google Scholar 

  592. Neyer U, Hoerandner H, Haid A, Zimmermann G, Niederle B (2002) Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection. Nephrol Dial Transplant 17 (4):625–629

    PubMed  Google Scholar 

  593. Nichol PF, Starling JR, Mack E, Klovning JJ, Becker BN, Chen H (2002) Long-term follow–up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma. Ann Surg 235 (5):673–678; discussion 678–680

    PubMed  Google Scholar 

  594. Nicholson ML, Veitch PS, Feehally J (1996) Parathyroidectomy in chronic renal failure: comparison of three operative strategies. J R Coll Surg Edinb 41 (6):382–387

    PubMed  CAS  Google Scholar 

  595. Niederle B (1996a) Secondary parathyroid hyperplasia surgical strategy: subtotal or total parathyroidectomy with autograft. Acta Chir Austriaca 28 Supp (124):4

    Google Scholar 

  596. Niederle B (1996b) The technique of parathyroid cryopreservation and results of delayed autotransplantation. Acta Chir Austriaca 28 Supp (124):6

    Google Scholar 

  597. Niederle B, Horandner H, Roka R, Woloszczuk W (1988a) [Parathyroidectomy and autotransplantation in renal hyperparathyroidism. I. Morphologic studies for tissue selection]. Langenbecks Arch Chir 373 (6):325–336

    PubMed  CAS  Google Scholar 

  598. Niederle B, Horandner H, Roka R, Woloszczuk W (1989a) Morphologic and functional studies to prevent graft-dependent recurrence in renal osteodystrophy. Surgery 106 (6):1043–1048

    PubMed  CAS  Google Scholar 

  599. Niederle B, Horandner H, Roka R, Woloszczuk W (1989b) [Parathyroidectomy and autotransplantation in renal hyperparathyroidism. I. Clinical and chemical laboratory studies following tissue selection]. Chirurg 60 (10):665–670

    PubMed  CAS  Google Scholar 

  600. Niederle B, Roka R, Brennan MF (1982) The transplantation of parathyroid tissue in man: development, indications, technique, and results. Endocr Rev 3 (3):245–279

    PubMed  CAS  Google Scholar 

  601. Niederle B, Roka R, Horandner H (1988b) [Recurrent renal hyperparathyroidism: reoperation on the autograft]. Wien Klin Wochenschr 100 (11):369–372

    PubMed  CAS  Google Scholar 

  602. Ockert S, Willeke F, Richter A, Jonescheit J, Schnuelle P, Van Der Woude F, Post S (2002) Total parathyroidectomy without autotransplantation as a standard procedure in the treatment of secondary hyperparathyroidism. Langenbecks Arch Surg 387 (5–6):204-209

    PubMed  Google Scholar 

  603. Ogg CS (1967) Total parathyroidectomy in treatment of secondary (renal) hyperparathyroidism. Br Med J 4 (5575):331–334

    PubMed  CAS  Google Scholar 

  604. Ohta K, Manabe T, Katagiri M, Harada T (1994) Expression of proliferating cell nuclear antigens in parathyroid glands of renal hyperparathyroidism. World J Surg 18 (4):625–628; discussion 628–629

    PubMed  CAS  Google Scholar 

  605. Park JH, Kang SW, Jeong JJ, Nam KH, Chang HS, Chung WY, Park CS (2011) Surgical treatment of tertiary hyperparathyroidism after renal transplantation: A 31-year experience in a single institution. Endocr J doi:JST.JSTAGE/endocrj/EJ11-0053 [pii]

    Google Scholar 

  606. Pattou FN, Pellissier LC, Noël C, Wambergue F, Huglo DG, Proye CA (2000) Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism. World J Surg 24 (11):1330–1334

    PubMed  CAS  Google Scholar 

  607. Périé S, Fessi H, Tassart M, Younsi N, Poli I, St Guily JL, Talbot JN (2005) Usefulness of combination of high-resolution ultrasonography and dual-phase dual-isotope iodine 123/technetium Tc 99 m sestamibi scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathyroidism. Am J Kidney Dis 45 (2):344–352

    PubMed  Google Scholar 

  608. Pitt SC, Panneerselvan R, Chen H, Sippel RS (2009) Tertiary hyperparathyroidism: is less than a subtotal resection ever appropriate? A study of long term outcomes. Surgery 146 (6):1130–1137

    PubMed  Google Scholar 

  609. Pitt SC, Panneerselvan R, Chen H, Sippel RS (2010) Secondary and tertiary hyperparathyroidism: the utility of ioPTH monitoring. World J Surg 34 (6):1343–1349

    PubMed  Google Scholar 

  610. Plosker GL (2011) Cinacalcet: a pharmacoeconomic review of its use in secondary hyperparathyroidism in end-stage renal disease. Pharmacoeconomics 29 (9):807–821

    PubMed  Google Scholar 

  611. Puccini M, Carpi A, Cupisti A, Caprioli R, Iacconi P, Barsotti M, Buccianti P, Mechanick J, Nicolini A, Miccoli P (2010) Total parathyroidectomy without autotransplantation for the treatment of secondary hyperparathyroidism associated with chronic kidney disease: clinical and laboratory long-term follow-up. Biomed Pharmacother 64 (5):359–362

    PubMed  CAS  Google Scholar 

  612. Rayes N, Seehofer D, Schindler R, Reinke P, Kahl A, Ulrich F, Neuhaus P, Nussler NC (2008) Long-term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients. Arch Surg 143 (8):756–761; discussion 761

    PubMed  Google Scholar 

  613. Richards ML, Wormuth J, Bingener J, Sirinek K (2006) Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management? Surgery 139 (2):174–180

    PubMed  Google Scholar 

  614. Roshan A, Kamath B, Roberts S, Atkin SL, England RJ (2006) Intra-operative parathyroid hormone monitoring in secondary hyperparathyroidism: is it useful? Clin Otolaryngol 31 (3):198–203

    PubMed  CAS  Google Scholar 

  615. Rothmund M, Wagner PK (1983) Total parathyroidectomy and autotransplantation of parathyroid tissue for renal hyperparathyroidism. A one- to six-year follow-up. Ann Surg 197 (1):7–16

    PubMed  CAS  Google Scholar 

  616. Rothmund M, Wagner PK (1987) Epithelkörperchentransplantation. Endokrine Chirurgie. Thieme, Stuttgart New York

    Google Scholar 

  617. Rothmund M, Wagner PK (1988) Reoperations for persistent and recurrent secondary hyperparathyroidism. Ann Surg 207 (3):310–314

    PubMed  CAS  Google Scholar 

  618. Rothmund M, Wagner PK, Schark C (1991) Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 15 (6):745–750

    PubMed  CAS  Google Scholar 

  619. Salem MM (1997) Hyperparathyroidism in the hemodialysis population: a survey of 612 patients. Am J Kidney Dis 29 (6):862-865

    PubMed  CAS  Google Scholar 

  620. Saunders RN, Karoo R, Metcalfe MS, Nicholson ML (2005) Four gland parathyroidectomy without reimplantation in patients with chronic renal failure. Postgrad Med J 81 (954):255–258

    PubMed  CAS  Google Scholar 

  621. Schlosser K, Endres N, Celik I, Fendrich V, Rothmund M, Fernandez ED (2007) Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! World J Surg 31 (10):1947–1953

    PubMed  Google Scholar 

  622. Schneider R, Waldmann J, Ramaswamy A, Fernández ED, Bartsch DK, Schlosser K (2011) Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy. World J Surg 35 (6):1260–1265

    PubMed  Google Scholar 

  623. Schwarz A, Rustien G, Merkel S, Radermacher J, Haller H (2007) Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant 22 (2):584–591

    PubMed  Google Scholar 

  624. Seehofer D, Rayes N, Klupp J, Steinmüller T, Ulrich F, Müller C, Schindler R, Frei U, Neuhaus P (2005) Predictive value of intact parathyroid hormone measurement during surgery for renal hyperparathyroidism. Langenbecks Arch Surg 390 (3):222–229

    PubMed  Google Scholar 

  625. Shih ML, Duh QY, Hsieh CB, Lin SH, Wu HS, Chu PL, Chen TY, Yu JC (2009) Total parathyroidectomy without autotransplantation for secondary hyperparathyroidism. World J Surg 33 (2):248–254

    PubMed  Google Scholar 

  626. Silver J (2000) Molecular mechanisms of secondary hyperparathyroidism. Nephrol Dial Transplant 15 Suppl 5:2–7

    PubMed  CAS  Google Scholar 

  627. Skinner KA, Zuckerbraun L (1996) Recurrent secondary hyperparathyroidism. An argument for total parathyroidectomy. Arch Surg 131 (7):724–727

    PubMed  CAS  Google Scholar 

  628. Stanbury SW, Lumb GA, Nicholson WF (1960) Selective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet 1:793

    PubMed  CAS  Google Scholar 

  629. Starr FL, DeCresce R, Prinz RA (2000) Normalization of intraoperative parathyroid hormone does not predict normal postoperative parathyroid hormone levels. Surgery 128 (6):930–935; discussion 935–936

    PubMed  CAS  Google Scholar 

  630. Stein MS, Packham DK, Wark JD, Ebeling PR, Becker GJ (1997) Large, rapid skeletal changes after parathyroidectomy. Clin Nephrol 48 (3):191–194

    PubMed  CAS  Google Scholar 

  631. Stracke S, Jehle PM, Sturm D, Schoenberg MH, Widmaier U, Beger HG, Keller F (1999) Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure. Am J Kidney Dis 33 (2):304–311

    PubMed  CAS  Google Scholar 

  632. Stracke S, Keller F, Steinbach G, Henne-Bruns D, Wuerl P (2009) Long-term outcome after total parathyroidectomy for the management of secondary hyperparathyroidism. Nephron Clin Pract 111 (2):c102–109

    PubMed  CAS  Google Scholar 

  633. Sun Y, Cai H, Bai J, Zhao H, Miao Y (2009) Endoscopic total parathyroidectomy and partial parathyroid tissue autotransplantation for patients with secondary hyperparathyroidism: a new surgical approach. World J Surg 33 (8):1674–1679

    PubMed  Google Scholar 

  634. Takagi H, Tominaga Y, Uchida K, Yamada N, Kawai M, Kano T, Morimoto T (1984) Subtotal versus total parathyroidectomy with forearm autograft for secondary hyperparathyroidism in chronic renal failure. Ann Surg 200 (1):18–23

    PubMed  CAS  Google Scholar 

  635. Tan CC, Cheah WK, Tan CT, Rauff A (2010) Intramuscular injection of parathyroid autografts is a viable option after total parathyroidectomy. World J Surg 34 (6):1332–1336

    PubMed  Google Scholar 

  636. Thompson NW, Eckhauser FE, Harness JK (1982) The anatomy of primary hyperparathyroidism. Surgery 92 (5):814–821

    PubMed  CAS  Google Scholar 

  637. Tominaga Y, Matsuoka S, Sato T (2005) Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial 9 (1):44–47

    PubMed  Google Scholar 

  638. Tominaga Y, Matsuoka S, Uno N (2009) Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis. World J Surg 33 (11):2335–2342

    PubMed  Google Scholar 

  639. Tominaga Y, Matsuoka S, Uno N, Sato T (2008) Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics. Ther Apher Dial 12 Suppl 1:S21–26

    PubMed  Google Scholar 

  640. Tominaga Y, Matsuoka S, Uno N, Tsuzuki T, Hiramitsu T, Goto N, Nagasaka T, Watarai Y, Uchida K (2010) Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients. World J Surg 34 (6):1312–1317

    PubMed  Google Scholar 

  641. Tominaga Y, Tanaka Y, Sato K, Numano M, Uchida K, Falkmer U, Grimelius L, Johansson H, Takagi H (1992) Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 16 (4):595–602; discussion 602–593

    PubMed  CAS  Google Scholar 

  642. Tominaga Y, Uchida K, Haba T, Katayama A, Sato T, Hibi Y, Numano M, Tanaka Y, Inagaki H, Watanabe I, Hachisuka T, Takagi H (2001) More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 38 (4 Suppl 1):S168–171

    PubMed  CAS  Google Scholar 

  643. Triponez F, Clark OH, Evenepoel P (2010) Response to „tertiary hyperparathyroidism: is less than a subtotal resection ever appropriate? A study on long-term outcomes“. Surgery 148 (5):1044–1045; author reply 1045

    PubMed  Google Scholar 

  644. Triponez F, Clark OH, Vanrenthergem Y, Evenepoel P (2008) Surgical treatment of persistent hyperparathyroidism after renal transplantation. Ann Surg 248 (1):18–30

    PubMed  Google Scholar 

  645. Triponez F, Dosseh D, Hazzan M, Noel C, Soudan B, Lokey J, Mozzon M, Proye CA (2006a) Accuracy of intra-operative PTH measurement during subtotal parathyroidectomy for tertiary hyperparathyroidism after renal transplantation. Langenbecks Arch Surg 391 (6):561–565

    PubMed  Google Scholar 

  646. Triponez F, Dosseh D, Hazzan M, Noel C, Vanhille P, Proye CA (2005) Subtotal parathyroidectomy with thymectomy for autonomous hyperparathyroidism after renal transplantation. Br J Surg 92 (10):1282–1287

    PubMed  CAS  Google Scholar 

  647. Triponez F, Kebebew E, Dosseh D, Duh QY, Hazzan M, Noel C, Chertow GM, Wambergue F, Fleury D, Lemaitre V, Proye CA, Clark OH (2006b) Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. Surgery 140 (6):990–997; discussion 997–999

    PubMed  Google Scholar 

  648. Uno N, Tominaga Y, Matsuoka S, Tsuzuki T, Shimabukuro S, Sato T, Goto N, Nagasaka T, Katayama A, Uchida K (2008) Incidence of parathyroid glands located in thymus in patients with renal hyperparathyroidism. World J Surg 32 (11):2516–2519

    PubMed  Google Scholar 

  649. Valderrabano F, Berthoux FC, Jones EH, Mehls O (1996) Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The EDTA-ERA Registry. European Dialysis and Transplant Association-European Renal Association. Nephrol Dial Transplant 11 Suppl 1:2–21

    PubMed  Google Scholar 

  650. Vulpio C, Bossola M, De Gaetano A, Maresca G, Bruno I, Fadda G, Morassi F, Magalini SC, Giordano A, Castagneto M (2010) Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative evaluation of uremic secondary hyperparathyroidism. Head Neck 32 (9):1226–1235

    PubMed  Google Scholar 

  651. Wada M, Nagano N (2003) Control of parathyroid cell growth by calcimimetics. Nephrol Dial Transplant 18 Suppl 3:iii13–17

    PubMed  Google Scholar 

  652. Wagner PK, Eckhardt J, Rothmund M (1991) [Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation in secondary hyperparathyroidism. A randomized study]. Chirurg 62 (3):189–194

    PubMed  CAS  Google Scholar 

  653. Wallfelt CH, Larsson R, Gylfe E, Ljunghall S, Rastad J, Akerstrom G (1988) Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implication for parathyroid autotransplantation. World J Surg 12 (4):431–438

    PubMed  CAS  Google Scholar 

  654. Weber T, Zeier M, Hinz U, Schilling T, Büchler MW (2005) Impact of intraoperative parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism. World J Surg 29 (9):1176–1179

    PubMed  Google Scholar 

  655. Wells SA, Gunnells JC, Shelburne JD, Schneider AB, Sherwood LM (1975) Transplantation of the parathyroid glands in man: clinical indications and results. Surgery 78 (1):34–44

    PubMed  Google Scholar 

  656. Welsh CL, Taylor GW, Cattell WR, Baker LR (1984) Parathyroid surgery in chronic renal failure: subtotal parathyroidectomy or autotransplantation? Br J Surg 71 (8):591–592

    PubMed  CAS  Google Scholar 

  657. Yamashita H, Cantor T, Uchino S, Watanabe S, Ogawa T, Moriyama T, Takamatsu Y, Fukagawa M, Noguchi S (2005) Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism. World J Surg 29 (2):169–173

    PubMed  Google Scholar 

  658. Yamashita H, Gao P, Cantor T, Noguchi S, Uchino S, Watanabe S, Ogawa T, Kawamoto H, Fukagawa M (2004) Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism. Surgery 135 (2):149–156

    PubMed  Google Scholar 

  659. Yoon JH, Nam KH, Chang HS, Chung WY, Park CS (2006) Total parathyroidectomy and autotransplantation by the subcutaneous injection technique in secondary hyperparathyroidism. Surg Today 36 (4):304–307

    PubMed  Google Scholar 

  660. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK (2005) Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 67 (3):1179–1187

    PubMed  CAS  Google Scholar 

  661. Akerstrom G, Rudberg C, Grimelius L, Rastad J (1988) Recurrent hyperparathyroidism due to peroperative seeding of neoplastic or hyperplastic parathyroid tissue. Case report. Acta Chir Scand 154 (9):549–552

    PubMed  CAS  Google Scholar 

  662. Baker LR, Otieno LS, Brown AL, Carroll MJ, Cattell WR, Farrington K (1991) Pitfalls after total parathyroidectomy and parathyroid autotransplantation in chronic renal failure. Am J Nephrol 11 (3):186–191

    PubMed  CAS  Google Scholar 

  663. Burgstaller T, Riss P, Asari R, Scheuba C, Bieglmayer C, Kaczirek K, Niederle B Does technically defined „total parathyroidectomy” stand the biochemical test? – A short and long-term follow-up of patients with secondary hyperparathyroidism. sent for publication

    Google Scholar 

  664. Casanova D, Sarfati E, De Francisco A, Amado JA, Arias M, Dubost C (1991) Secondary hyperparathyroidism: diagnosis of site of recurrence. World J Surg 15 (4):546–549; discussion 549–550

    PubMed  CAS  Google Scholar 

  665. Cattan P, Halimi B, Aïdan K, Billotey C, Tamas C, Drüeke TB, Sarfati E (2000) Reoperation for secondary uremic hyperparathyroidism: are technical difficulties influenced by initial surgical procedure? Surgery 127 (5):562–565

    PubMed  CAS  Google Scholar 

  666. Conzo G, Perna AF, Sinisi AA, Palazzo A, Stanzione F, Della Pietra C, Livrea A (2011) Total parathyroidectomy without autotransplantation in the surgical treatment of secondary hyperparathyroidism of chronic kidney disease. J Endocrinol Invest. doi:7621 [pii] 10.3275/7621

    Google Scholar 

  667. De Francisco AL, Amado JA, Casanova D, Briz E, Riancho J, Cotorruelo J, de Bonis E, Canga E, Arias M (1991) Recurrence of hyperparathyroidism after total parathyroidectomy with autotransplantation: a new technique to localize the source of hormone excess. Nephron 58 (3):306–309

    PubMed  Google Scholar 

  668. Debruyne F, Geuens G, Vander Poorten V, Delaere P (2008) Re-operation for secondary hyperparathyroidism. J Laryngol Otol 122 (9):942–947

    PubMed  CAS  Google Scholar 

  669. Dionisio P, Stramignoni E, Passarino G, Pucci A, Valenti M, Berto IM, Portigliatti Barbos M, Cadario A, Gasparri G, Bajardi P (1996) Recurrent secondary hyperparathyroidism due to parathyroid carcinoma: usefulness of Ki-67 immunostaining in the diagnosis of a malignant parathyroid tumor. Nephron 74 (4):720–723

    PubMed  CAS  Google Scholar 

  670. Dotzenrath C, Cupisti K, Goretzki E, Mondry A, Vossough A, Grabensee B, Röher HD (2003) Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg 387 (9–10):348–354

    PubMed  CAS  Google Scholar 

  671. Dubost C, Kracht M, Assens P, Sarfati E, Zingraff J, Drueke T (1986) Reoperation for secondary hyperparathyroidism in hemodialysis patients. World J Surg 10 (4):654–660

    PubMed  CAS  Google Scholar 

  672. Gasparri G, Camandona M, Abbona GC, Papotti M, Jeantet A, Radice E, Mullineris B, Dei Poli M (2001) Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg 233 (1):65–69

    PubMed  CAS  Google Scholar 

  673. Hampl H, Steinmuller T, Stabell U, Klingenberg HJ, Schnoy N, Neuhaus P (1991) Recurrent hyperparathyroidism after total parathyroidectomy and autotransplantation in patients with long-term hemodialysis. Miner Electrolyte Metab 17 (4):256–260

    PubMed  CAS  Google Scholar 

  674. Henry JF, Denizot A, Audiffret J, France G (1990) Results of reoperations for persistent or recurrent secondary hyperparathyroidism in hemodialysis patients. World J Surg 14 (3):303–306; discussion 307

    PubMed  CAS  Google Scholar 

  675. Hergan K, Neyer U, Doringer W, Mündle M (1995) MR imaging in graft-dependent recurrent hyperparathyroidism after parathyroidectomy and autotransplantation. J Magn Reson Imaging 5 (5):541–544

    PubMed  CAS  Google Scholar 

  676. Hibi Y, Tominaga Y, Sato T, Katayama A, Haba T, Uchida K, Ichimori T, Numano M, Tanaka Y, Takagi H, Imai T, Funahashi H, Nakao A (2002) Reoperation for renal hyperparathyroidism. World J Surg 26 (10):1301–1307

    PubMed  Google Scholar 

  677. Higgins RM, Richardson AJ, Ratcliffe PJ, Woods CG, Oliver DO, Morris PJ (1991) Total parathyroidectomy alone or with autograft for renal hyperparathyroidism? Q J Med 79 (288):323–332

    PubMed  CAS  Google Scholar 

  678. Kessler M, Avila JM, Renoult E, Mathieu P (1991) Reoperation for secondary hyperparathyroidism in chronic renal failure. Nephrol Dial Transplant 6 (3):176–179

    PubMed  CAS  Google Scholar 

  679. Khan MW, Worcester EM, Straus FH, 2nd, Khan S, Staszak V, Kaplan EL (2004) Parathyroid carcinoma in secondary and tertiary hyperparathyroidism. J Am Coll Surg 199 (2):312–319

    PubMed  Google Scholar 

  680. Kinnaert P, Tielemans C, Dhaene M, Decoster-Gervy C (1998) Evaluation of surgical treatment of renal hyperparathyroidism by measuring intact parathormone blood levels on first postoperative day. World J Surg 22 (7):695–699

    PubMed  CAS  Google Scholar 

  681. Klempa I, Rottger P, Schneider M, Frei U, Koch KM (1982) [Transplantation hyperparathyroidism – tumorlike growth and autonomous function of autografts of the hyperplastic parathyroid (author's transl)]. Langenbecks Arch Chir 356 (3):191–204

    PubMed  CAS  Google Scholar 

  682. Korzets Z, Magen H, Kraus L, Bernheim J (1987) Total parathyroidectomy with autotransplantation in haemodialysed patients with secondary hyperparathyroidism – should it be abandoned? Nephrol Dial Transplant 2 (5):341–346

    PubMed  CAS  Google Scholar 

  683. Krutak-Krol H, Mace C, Nichols WK, Singh A, Twardowski ZJ (1989) Diagnostic dilemma of an unsuspected hyperfunctioning accessory parathyroid gland after total parathyroidectomy with autotransplantation in a peritoneal dialysis patient. Am J Nephrol 9 (6):495–498

    PubMed  CAS  Google Scholar 

  684. Kumar A, Kumar S, Aggarwal S, Kumar R, Tandon N (2002) Thoracoscopy: the preferred method for excision of mediastinal parathyroids. Surg Laparosc Endosc Percutan Tech 12 (4):295–300

    PubMed  Google Scholar 

  685. Low TH, Clark J, Gao K, Eris J, Shannon K, O'Brien C (2009) Outcome of parathyroidectomy for patients with renal disease and hyperparathyroidism: predictors for recurrent hyperparathyroidism. ANZ J Surg 79 (5):378–382

    PubMed  Google Scholar 

  686. Matsuoka S, Tominaga Y, Sato T, Uno N, Goto N, Katayama A, Uchida K, Tsuzuki T (2007) Recurrent renal hyperparathyroidism caused by parathyromatosis. World J Surg 31 (2):299–305

    PubMed  Google Scholar 

  687. Miki H, Sumitomo M, Inoue H, Kita S, Monden Y (1996) Parathyroid carcinoma in patients with chronic renal failure on maintenance hemodialysis. Surgery 120 (5):897–901

    PubMed  CAS  Google Scholar 

  688. Moor JW, Roberts S, Atkin SL, England RJ (2011) Intraoperative parathyroid hormone monitoring to determine long-term success of total parathyroidectomy for secondary hyperparathyroidism. Head Neck 33 (3):293–296

    PubMed  Google Scholar 

  689. Nakatsuka K, Nishizawa Y, Ishimura E, Miki T, Hagiwara S, Morita A, Inoue S, Morii H (1989) The fifth hyperfunctioning parathyroid gland in end-stage renal disease. Nephron 51 (1):140–142

    PubMed  CAS  Google Scholar 

  690. Neyer U, Hoerandner H, Haid A, Zimmermann G, Niederle B (2002) Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection. Nephrol Dial Transplant 17 (4):625–629

    PubMed  Google Scholar 

  691. Niederle B (1996) Secondary parathyroid hyperplasia surgical strategy: subtotal or total parathyroidectomy with autograft. Acta Chir Austriaca 28 Supp (124):4

    Google Scholar 

  692. Niederle B, Horandner H, Roka R, Woloszczuk W (1988a) [Parathyroidectomy and autotransplantation in renal hyperparathyroidism. I. Morphologic studies for tissue selection]. Langenbecks Arch Chir 373 (6):325–336

    PubMed  CAS  Google Scholar 

  693. Niederle B, Horandner H, Roka R, Woloszczuk W (1989) [Parathyroidectomy and autotransplantation in renal hyperparathyroidism. I. Clinical and chemical laboratory studies following tissue selection]. Chirurg 60 (10):665–670

    PubMed  CAS  Google Scholar 

  694. Niederle B, Roka R, Horandner H (1988b) [Recurrent renal hyperparathyroidism: reoperation on the autograft]. Wien Klin Wochenschr 100 (11):369–372

    PubMed  CAS  Google Scholar 

  695. Rattner DW, Marrone GC, Kasdon E, Silen W (1985) Recurrent hyperparathyroidism due to implantation of parathyroid tissue. Am J Surg 149 (6):745–748

    PubMed  CAS  Google Scholar 

  696. Richards ML, Wormuth J, Bingener J, Sirinek K (2006) Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management? Surgery 139 (2):174–180

    PubMed  Google Scholar 

  697. Schlosser K, Rothmund M, Maschuw K, Barth PJ, Vahl TP, Suchan KL, Fernández ED (2008) Graft-dependent renal hyperparathyroidism despite successful kidney transplantation. World J Surg 32 (4):557–565

    PubMed  CAS  Google Scholar 

  698. Schlosser K, Sitter H, Rothmund M, Zielke A (2004) Assessing the site of recurrence in patients with secondary hyperparathyroidism by a simplified Casanova autograftectomy test. World J Surg 28 (6):583–588

    PubMed  Google Scholar 

  699. Schlosser K, Veit JA, Witte S, Fernández ED, Victor N, Knaebel HP, Seiler CM, Rothmund M (2007) Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial. Trials 8:22

    PubMed  Google Scholar 

  700. Seehofer D, Steinmuller T, Rayes N, Podrabsky P, Riethmuller J, Klupp J, Ulrich F, Schindler R, Frei U, Neuhaus P (2004) Parathyroid hormone venous sampling before reoperative surgery in renal hyperparathyroidism: comparison with noninvasive localization procedures and review of the literature. Arch Surg 139 (12):1331–1338

    PubMed  Google Scholar 

  701. Takebayashi S, Matsui K, Nozawa T, Fujioka E, Hidai H (1990) Hyperplasia of autotransplanted parathyroid in the forearm. Clin Nucl Med 15 (5):354–355

    PubMed  CAS  Google Scholar 

  702. Tominaga Y, Matsuoka S, Uno N, Sato T (2008a) Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics. Ther Apher Dial 12 Suppl 1:S21–26

    PubMed  Google Scholar 

  703. Tominaga Y, Matsuoka S, Uno N, Tsuzuki T, Hiramitsu T, Goto N, Nagasaka T, Watarai Y, Uchida K (2010) Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients. World J Surg 34 (6):1312–1317

    PubMed  Google Scholar 

  704. Tominaga Y, Numano M, Tanaka Y, Uchida K, Takagi H (1997) Surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13 (2):87–96

    PubMed  CAS  Google Scholar 

  705. Tominaga Y, Numano M, Uchida K, Sato K, Asano H, Haba T, Katayama A, Mukoyama A, Suzuki K, Tanaka Y, et al. (1995) Lung metastasis from parathyroid carcinoma causing recurrent renal hyperparathyroidism in a hemodialysis patient: report of a case. Surg Today 25 (11):984–986

    PubMed  CAS  Google Scholar 

  706. Tominaga Y, Tanaka Y, Sato K, Numano M, Uchida K, Falkmer U, Grimelius L, Johansson H, Takagi H (1992) Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 16 (4):595–602; discussion 602–593

    PubMed  CAS  Google Scholar 

  707. Tominaga Y, Tsuzuki T, Matsuoka S, Uno N, Sato T, Shimabukuro S, Goto N, Nagasaka T, Uchida K (2008b) Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease. World J Surg 32 (5):815–821

    PubMed  Google Scholar 

  708. Wagner PK, Eckhardt J, Rothmund M (1991) [Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation in secondary hyperparathyroidism. A randomized study]. Chirurg 62 (3):189–194

    PubMed  CAS  Google Scholar 

  709. Wagner PK, Rothmund M (1987) [Reoperations in persistent and recurrent secondary hyperparathyroidism]. Chirurg 58 (8):543–548

    PubMed  CAS  Google Scholar 

  710. Winkelbauer F, Ammann M, Langle F, Niederle B, Lechner G (1993) [The sonographic diagnosis of recurrences after parathyroid autotransplantation. The preliminary results of a prospective study]. Rofo 158 (1):39–42

    PubMed  CAS  Google Scholar 

  711. Arlt W, Fremerey C, Callies F, Reincke M, Schneider P, Timmermann W, Allolio B (2002) Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol 146:215–222

    PubMed  CAS  Google Scholar 

  712. Avsar A, Dogan A, Tavli T (2004) A rare cause of reversible dilated cardiomyopathy: hypocalcemia. Echocardiography 21:609–612

    PubMed  Google Scholar 

  713. Chan FK, Tiu SC, Choi KL, Choi CH, Kong AP, Shek CC (2003) Increased bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 88:3155–3159

    PubMed  CAS  Google Scholar 

  714. Hermann M, Ott J, Promberger R, Kober F, Karik M, Freissmuth M (2008) Kinetics of serum parathyroid hormone during and after thyroid surgery. Brit J Surgery 95:1480–14807

    CAS  Google Scholar 

  715. Kihara M, Miyauchi A, Kontani K, Yamauchi A, Yokomise H (2005) Recovery of parathyroid function after total thyroidectomy: long-term follow-up study. ANZ J Surg 75:532–536

    PubMed  Google Scholar 

  716. Quack I, Zwernemann C, Weiner SM, Sellin L, Henning BF, Waldherr R, Buchner NJ, Stegbauer J, Vonend O, Rump LC (2005) Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review. Exp Clin Endocrinol Diabetes 113:376–380

    PubMed  CAS  Google Scholar 

  717. Rastogi R, Beauchamp NJ, Ladenson PW (2003) Calcification of the basal ganglia in chronic hypoparathyroidism. J Clin Endocrinol Metab 88:1476–1477

    PubMed  CAS  Google Scholar 

  718. Sitges-Serra A, Ruiz S, Girvent M, Manjon H, Duenas JP, Sancho JJ (2010) Outcome of protracted hypoparathyroidism after total thyreoidectomy. Brit J Surg 97:1687–1695

    PubMed  CAS  Google Scholar 

  719. Tartaglia F, Giuliani A, Sgueglia M, Biancari F, Juvonen T, Campana FP (2005) Randomized study on oral administration of calcitriol to prevent symptomatic hypocalcemia after total thyroidectomy. Am J Surg 190:424–429

    PubMed  CAS  Google Scholar 

  720. Thomusch O, Machens A, Sekulla C, Ukkat J, Lippert H, Gastinger I, Dralle H (2000) Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg 24:1335–1341

    PubMed  CAS  Google Scholar 

  721. Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB Jr. (2003) Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab 88:4214–4220

    PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. T. Schilling

    Present address: Katharinenhospital, Kriegsbergstraße 60, 70174 , Stuttgart, Deutschland

  2. M. Rothmund, E. Karakas & K. Schlosser

    Present address: Dekanat Medizin, Philipps-Universität Marburg, Baldingerstr., 35043, Marburg, Deutschland

  3. M. Dietel

    Present address: Institut für Pathologie, Humboldt-Universität Berlin, Schumannstr. 20–21, 10117 , Berlin, Deutschland

  4. E. Blind

    Present address: Canary Wharf, European Medicines Agency (EMEA), 7 Westferry Circus, E14 4HB, London, Großbritannien

  5. M. Gotthardt

    Present address: Nucleaire Geneeskunde, Universitair Medisch Centrum St. Radboud, 9101, 6500 , HB Nijmegen, Niederlande

  6. Th. Clerici

    Present address: Klinik für Chirurgie, Kantonsspital St. Gallen, Rorschacherstr., 9007 , St. Gallen, Schweiz

  7. K. Lorenz

    Present address: Klinik für Allgemein-, Visceral- und Gefäßchirurgie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Str. 40, 06120, Halle (Saale), Deutschland

  8. A. Bergenfelz

    Present address: Dept. of Surgery, Lund University Hospital, Getingevägen 4, 22185, Lund, Deutschland

  9. B. Niederle

    Present address: Klinik für Allgemeinchirurgie, Universitätsklinik für Chirurgie, Währinger Gürtel 18–20, 1090 , Wien, Österreich

  10. D. Weismann

    Present address: Medizinische Klinik und Poliklinik I, Endokrinologie und Diabetologie, Universitätsklinikum Würzburg, Josef-Schneider-Str., 97080 , Würzburg, Deutschland

Authors and Affiliations

    Authors
    1. T. Schilling
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. M. Rothmund
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. M. Dietel
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. E. Blind
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. M. Gotthardt
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Th. Clerici
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. K. Lorenz
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. E. Karakas
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. A. Bergenfelz
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. B. Niederle
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. K. Schlosser
      View author publications

      You can also search for this author in PubMed Google Scholar

    12. D. Weismann
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to M. Rothmund .

    Editor information

    Editors and Affiliations

    1. Universitätsklinikum Freiburg, Hugstetter Str. 49, Freiburg, 79106, Germany

      Jörg Rüdiger Siewert

    2. Med. Zentrum für Operative Medizin I, Klinik für Allgemeinchirurgie, Univ.Klinikum Marburg, Baldingerstr., Marburg, 35033, Germany

      Matthias Rothmund

    3. Universitätsklinikum, Chirurgische Klinik und Poliklinik, RWTH Aachen, Pauwelsstr. 30, Aachen, 52074, Germany

      Volker Schumpelick

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2013 Springer-Verlag Berlin Heidelberg

    About this chapter

    Cite this chapter

    Schilling, T. et al. (2013). Nebenschilddrüsen. In: Siewert, J., Rothmund, M., Schumpelick, V. (eds) Praxis der Viszeralchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-14285-7_3

    Download citation

    • DOI: https://doi.org/10.1007/978-3-642-14285-7_3

    • Published:

    • Publisher Name: Springer, Berlin, Heidelberg

    • Print ISBN: 978-3-642-14284-0

    • Online ISBN: 978-3-642-14285-7

    • eBook Packages: Medicine (German Language)

    Publish with us

    Policies and ethics

    Search

    Navigation